[
    {"Q": "安寶錠的藥品是多少毫克每錠？", "A": "10mg/tab"},
    {"Q": "安寶錠是哪種藥品？", "A": "Ritodrine 口服"},
    {"Q": "安寶錠的學名是如何確定的？", "A": "Ritodrine" },
    {"Q": "安寶錠的商品名是如何確定的？", "A": "Anpo" }  ,
    {"Q": "安寶錠的學名成份是如何被確定的?", "A": "Ritodrine 10 mg" }  ,
    {"Q": "安寶錠的規格含量是多少？", "A": "10mg/tab" }  ,
    {"Q": "安寶錠的中文名是如何確定的？", "A": "安寶錠的中文名是安寶錠" }  ,
    {"Q": "安寶錠的藥理分類是什麼?", "A": "Uterine Relaxants" },
    {"Q": "安寶錠的健保碼是如何取得的？", "A": "AB37196100" },
    {"Q": "安寶錠的衛署字號是多少號？", "A": "衛署藥製字第037196號" },
    {"Q": "安寶錠的廠牌是由哪家公司生產的?", "A": "信東" }  ,
    {"Q": "安寶錠是在哪裡生產的？", "A": "臺灣" },
    {"Q": "安寶錠應該怎麼服用?", "A": "口服" },
    {"Q": "成人劑量安寶錠的初次給藥是多少毫克？", "A": "10 mg" },
    {"Q": "什麼時候開始給予成人劑量的安寶錠？", "A": "30 min before IVD is discontinued" },
    {"Q": "在初次給藥後，成人劑量安寶錠需要每隔多久重複給藥一次？", "A": "q2h for 24 hr" },
    {"Q": "維持期的成人劑量安寶錠需要每隔多久重複給藥一次？", "A": "q4-6h" },
    {"Q": "安寶錠如何安胎？", "A": "安寶錠的作用是安胎" },
    {"Q": "頭痛這個副作用是如何止痛的？", "A": "頭痛"},
    {"Q": "安寶錠應該如何儲存？", "A": "在 25°C以下儲存" },
    {"Q": "喜華膜衣錠的藥品如何服用?", "A": "口服" }  ,
    {"Q": "喜華膜衣錠的學名是什麼?", "A": "Cefuroxime"},
    {"Q": "如何寫出喜華膜衣錠的學名?", "A": "Cefuroxime"},
    {"Q": "喜華膜衣錠的學名如何拼寫?", "A": "Cefuroxime"},
    {"Q": "怎麼才能知道喜華膜衣錠的商品名？", "A": "可以檢視藥品包裝資料" },
    {"Q": "喜華膜衣錠的學名成份是多少毫克？", "A": "250 mg" }  ,
    {"Q": "喜華膜衣錠的規格含量是多少mg/tab?", "A": "250mg/tab" },
    {"Q": " 「如何稱呼喜華膜衣錠？」", "A": "「喜華膜衣錠的中文名是喜華膜衣錠」" },
    {"Q": "", "A": "" },
    {"Q": "喜華膜衣錠的健保碼是怎麼取得的？", "A": "AC45671100"}  ,
    {"Q": "這個藥品的衛署字號是如何取得的？", "A": "喜華膜衣錠的衛署字號是衛署藥製字第045671號" }  ,
    {"Q": "喜華膜衣錠的廠牌是什麼公司？", "A": "Yung Shin（永信）" },
    {"Q": "喜華膜衣錠是在哪裡生產的?", "A": "臺灣" },
    {"Q": "用於淋病的喜華膜衣錠劑量是多少？", "A": "1 g 作為單次劑量"},
    {"Q": "小孩三個月以上的喜華膜衣錠劑量是多少？", "A": "125 mg q12h"},
    {"Q": "_otitis media 小孩未滿二歲的喜華膜衣錠劑量是多少？", "A": "125 mg q12h"},
    {"Q": "otitis media 小孩兩歲以上的喜華膜衣錠劑量是多少？", "A": "250 mg q12h"},
    {"Q": "喜華膜衣錠的抗生素作用是如何發揮的？", "A": "喜華膜衣錠的作用是抗生素" }  ,
    {"Q": "喜華膜衣錠的皮疹副作用如何避免？", "A": "皮疹"},
    {"Q": "肝功能異常在使用喜華膜衣錠時如何監控？", "A": "肝功能異常"},
    {"Q": "當出現胃腸不適副作用時，.喜華膜衣錠如何調整用量？", "A": "胃腸不適"},
    {"Q": "為什麼使用喜華膜衣錠會導致暈眩？", "A": "暈眩"},
    {"Q": "腹瀉副作用在服用喜華膜衣錠後如何治療？", "A": "腹瀉"},
    {"Q": "嘔吐副作用在使用喜華膜衣錠時如何預防？", "A": "嘔吐"},
    {"Q": "蕁麻疹副作用在服用喜華膜衣錠後如何處理？", "A": "蕁麻疹"},
    {"Q": "喜華膜衣錠應該儲存在多少°C以下?", "A": "小於 25°C" }  ,
    {"Q": "喜華膜衣錠怎麼服用？", "A": "口服"},
    {"Q": "喜華膜衣錠不能怎樣處理？", "A": "不宜磨粉"},
    {"Q": "服用喜華膜衣錠需要遵守什麼原則？", "A": "請按時服藥至療程結束"},
    {"Q": "cephalosporin對penicillin過敏的患者應如何特別小心？", "A": "使用cephalosporin類藥品應特別小心。" },
    {"Q": "「哈寧錠的藥品是如何劑量的？」", "A": "「哈寧錠的藥品是 Haloperidol 口服 5mg/tab (Halin)」" },
    {"Q": "哈寧錠的學名是什麼方式確定的？", "A": "哈寧錠的學名是 Haloperidol" }  ,
    {"Q": "「哈寧錠的商品名是如何確定的？」", "A": "「哈寧錠的商品名是Halinh定義的。」" }  ,
    {"Q": "哈寧錠的有效成份是多少毫克?", "A": "5 mg" }  ,
    {"Q": "", "A": ""},
    {"Q": "「哈寧錠的中文名是什麼時候確定的？」", "A": "「哈寧錠」" }  ,
    {"Q": "「哈寧錠的藥理分類是什麼型別？」", "A": "「典型抗精神病藥」" },
    {"Q": "哈寧錠的健保碼是如何取得的？", "A": "AC31505100"},
    {"Q": "我們可以在哪裡找到哈寧錠的健保碼？", "A": "AC31505100"},
    {"Q": " 哈寧錠的健保碼是怎麼被分配的？", "A": "AC31505100"},
    {"Q": "哈寧錠的健保碼是如何生成的？", "A": "AC31505100"},
    {"Q": "哈寧錠的衛署字號是多少號?", "A": "衛署藥製字第031505號" },
    {"Q": "哈寧錠的廠牌是由誰生產？", "A": "Yusheng Pharmaceutical Co.Ltd（優生）"},
    {"Q": " 哈寧錠的製造商是哪一家公司？", "A": "Yusheng Pharmaceutical Co.Ltd（優生）"},
    {"Q": " 哈寧錠的生產廠牌名稱為何？", "A": "Yusheng Pharmaceutical Co.Ltd（優生）"},
    {"Q": "「哈寧錠的產地是哪裡？」", "A": "「臺灣」"},
    {"Q": "成人服用哈寧錠的劑量是如何?", "A": "6-15毫克/天，維持劑量為15-20毫克/天"},
    {"Q": "老年或衰弱患者服用哈寧錠的劑量是如何?", "A": "初始劑量為0.5-1.5毫克，維持劑量為2-8毫克/天"},
    {"Q": "智慧退化伴隨hyperactivity患者服用哈寧錠的劑量是如何?", "A": "初始劑量為80-120毫克/天，逐漸減少至維持劑量60毫克/天"},
    {"Q": "成人 Tourette綜合症患者服用哈寧錠的劑量是如何?", "A": "初始劑量為6-15毫克/天，分次給藥，維持劑量為9毫克/天"},
    {"Q": "抗精神病藥的小孩劑量是如何計算的？", "A": "0.05-0.15 mg/kg/day in 2-3 divided doses."},
    {"Q": "투蕾特氏綜合症的小孩劑量是如何給定的？", "A": "PO Child 3-12 yr: 0.05-0.075 mg/kg/day."},
    {"Q": "哈寧錠的止吐作用是如何實現的？", "A": "哈寧錠的作用是止吐"},
    {"Q": "哈寧錠如何穩定情緒？", "A": "哈寧錠的作用是情緒穩定劑"},
    {"Q": "在哪些情況下哈寧錠的止吐效果最好？", "A": "哈寧錠的作用是止吐"},
    {"Q": "哈寧錠如何平衡情緒？", "A": "哈寧錠的作用是情緒穩定劑"},
    {"Q": "哈寧錠對於止吐和情緒穩定的機理是什麼？", "A": "哈寧錠的作用是止吐, emotions穩定劑"},
    {"Q": "哈寧錠的口乾副作用如何避免？", "A": "哈寧錠的副作用包含口乾"},
    {"Q": "如何減少哈寧錠引起的失眠問題？", "A": "哈寧錠的副作用包含失眠"},
    {"Q": "哈寧錠引起皮疹的副作用如何治療？", "A": "哈寧錠的副作用包含皮疹"},
    {"Q": "如何預防哈寧錠引起的便秘問題？", "A": "哈寧錠的副作用包含便秘"},
    {"Q": "哈寧錠引起姿態性低血壓的副作用如何控制？", "A": "哈寧錠的副作用包含姿態性低血壓"},
    {"Q": "哈寧錠引起視力模糊的副作用如何改善？", "A": "哈寧錠的副作用包含視力模糊"},
    {"Q": "如何減少哈寧錠引起的嗜睡問題？", "A": "哈寧錠的副作用包含嗜睡"},
    {"Q": "哈寧錠引起體重增加的副作用如何控制？", "A": "哈寧錠的副作用包含體重增加"},
    {"Q": "哈寧錠應該如何儲存?", "A": "15-30°C儲存" },
    {"Q": "哈寧錠的用法是怎樣的？", "A": "口服" },
    {"Q": "哈寧錠的用藥指導是為什麼避免操作機械或駕車？", "A": "避免操作機械或駕車" },
    {"Q": "對於老年人及糖尿病人，應如何調整起始劑量？", "A": "應降低"},
    {"Q": "怎樣正確地配製 Peyona 口服液？", "A": "輸注溶液及口服液"},
    {"Q": "", "A": ""},
    {"Q": ".peyona?", "A": ". Peyona"   },
    {"Q": "?peyona?", "A": ". Peyona"   },
    {"Q": "輸注溶液及口服液的學名成份要如何計算？", "A": "Caffeine Citrate 20 mg/mL"},
    {"Q": "怎樣準備輸注溶液及口服液的學名成份？", "A": "Caffeine Citrate 20 mg/mL"},
    {"Q": "輸注溶液及口服液的學名成份需要如何配製？", "A": "Caffeine Citrate 20 mg/mL"},
    {"Q": "輸注溶液及口服液的學名成份是如何制備的？", "A": "Caffeine Citrate 20 mg/mL"},
    {"Q": "要如何準備輸注溶液及口服液的學名成份以供給病人？", "A": "Caffeine Citrate 20 mg/mL"},
    {"Q": "", "A": "" }  ,
    {"Q": "啡那輸注溶液及口服液的中文名是什麼？", "A": "啡那輸注溶液及口服液" }  ,
    {"Q": "輸注溶液及口服液的藥理分類是什麼時候決定?", "A": "Xanthine derivatives" },
    {"Q": "誰決定輸注溶液及口服液的藥理分類為?", "A": "Xanthine derivatives" },
    {"Q": "輸注溶液及口服液的藥理分類是根據什麼標準確定?", "A": "Xanthine derivatives" },
    {"Q": "「輸注溶液及口服液的衛署字號是如何取得的？」,<|begin_of_text|>1993年取得，", "A": "「衛部藥輸字第027090號」" },
    {"Q": "阿法西格馬有限公司生產的輸注溶液及口服液是什麼?", "A": "啡那" },
    {"Q": "輸注溶液及口服液的產地是哪個國家？", "A": "義大利"},
    {"Q": "輸注溶液及口服液是在哪個地方生產的？", "A": "義大利"},
    {"Q": "小孩輸注劑量的啡那loading dose是多少？", "A": "20 mg/kg caffeine citrate"},
    {"Q": "維持劑量的給藥頻率是多少次每日？", "A": "一次每日"},
    {"Q": "口服維持劑量和輸注維持劑量的劑量是一樣的嗎？", "A": "都是 5 mg/kg/dose caffeine citrate"},
    {"Q": "啡那loading dose給藥後多久開始給予維持劑量？", "A": "24 小時"},
    {"Q": "輸注溶液及口服液是如何幫助早產兒的？", "A": "早產兒呼吸暫停"},
    {"Q": "什麼情況下需要使用輸注溶液及口服液來幫助早產兒？", "A": "早產兒呼吸暫停"},
    {"Q": "醫生如何決定是否給早產兒使用輸注溶液及口服液？", "A": "早產兒呼吸暫停"},
    {"Q": "輸注溶液及口服液是如何預防早產兒呼吸暫停的？", "A": "早產兒呼吸暫停"},
    {"Q": "輸注溶液及口服液可能引起的心搏過速是如何處理的？", "A": "心搏過速"},
    {"Q": "為什麼會出現血糖異常的副作用？", "A": "血糖異常"},
    {"Q": "靜脈炎這個副作用是如何預防或治療的？", "A": "靜脈炎"},
    {"Q": "", "A": "" },
    {"Q": "輸注溶液及口服液應如何給予？", "A": "可靜脈注射或口服給予"},
    {"Q": "這些藥品能夠透過哪種方式給藥？", "A": "可靜脈注射或口服給予"},
    {"Q": "醫療人員在給藥時需要遵循什麼步驟？", "A": "可靜脈注射或口服給予"},
    {"Q": "「如何衡量一毫升啡那輸注溶液及口服液中的咖啡因？」", "A": "「每 mL 含有 20mg caffeine citrate (相當於 caffeine 10mg)」" },
    {"Q": "導美睡錠的藥品如何取得？", "A": "Midazolam 口服 7.5mg/tab (Dormicum)"},
    {"Q": "哪種藥品是導美睡錠的主要成分？", "A": "Midazolam 口服 7.5mg/tab (Dormicum)"},
    {"Q": "導美睡錠的劑量是多少毫克每錠？", "A": "7.5mg/tab"},
    {"Q": "導美睡錠的學名是如何確定的？", "A": "Midazolam"},
    {"Q": "導美睡錠的商品名是如何確定的？", "A": " Dormicum"},
    {"Q": "導美睡錠的學名成份是如何得知的?", "A": "Midazolam 7.5 mg" }  ,
    {"Q": "導美睡錠的規格含量是多少mg/tab?", "A": "7.5mg/tab" },
    {"Q": "「導美睡錠的中文名是什麼命名過程？」", "A": "「導美睡錠」" }  ,
    {"Q": "導美睡錠的藥理分類是什麼類別?", "A": "Benzodiazepines" },
    {"Q": "導美睡錠的健保碼是什麼時候取得的？", "A": "BC17577100"},
    {"Q": "如何知道導美睡錠的健保碼是多少？", "A": "BC17577100"},
    {"Q": "要怎麼樣才可以找到導美睡錠的健保碼？", "A": "BC17577100"},
    {"Q": "導美睡錠的衛署字號是如何取得的？", "A": "衛署藥輸字第017577號" },
    {"Q": "導美睡錠的廠牌是由哪一家公司生產？", "A": "Recipharm Leganes S.L.U.(Recipharm)" },
    {"Q": "「導美睡錠的產地是在哪個國家製造？」", "A": "「西班牙」" },
    {"Q": "術前medication時，每次給多少毫克的導美睡錠？", "A": "15 mg"},
    {"Q": "導美睡錠的作用是如何協助放鬆情緒?", "A": "導美睡錠的作用是協助放鬆情緒" },
    {"Q": "導美睡錠的幻覺副作用如何避免？", "A": "幻覺"},
    {"Q": "導美睡錠引起倦怠副作用是如何發生的？", "A": "倦怠"},
    {"Q": "為何導美睡錠會引起健忘副作用？", "A": "健忘"},
    {"Q": "導美睡錠的嗜睡副作用如何緩解？", "A": "嗜睡"},
    {"Q": "導美睡錠的憂鬱副作用是如何治療的？", "A": "憂鬱"},
    {"Q": "導美睡錠引起頭痛副作用需要怎麼做？", "A": "頭痛"},
    {"Q": "導美睡錠應該如何儲存？", "A": "小於 30°C 儲存"},
    {"Q": "導美睡錠應該怎麼服用？", "A": "口服"},
    {"Q": "導美睡錠使用時需要避免什麼活動？", "A": "操作機械或駕車"},
    {"Q": "如何確定不應將導美睡錠用於哪些病人？", "A": "肌無力的病人"},
    {"Q": "口服液鉀補的藥品需要如何儲存？", "A": "根據說明書，該藥品應該儲存在密閉容器中，並置於兒童無法觸及的地方。" }  ,
    {"Q": "鉀補口服液的學名是如何獲得的?", "A": "鉀補口服液的學名是 Potassium Gluconate" },
    {"Q": "誰可以告訴我鉀補口服液的學名?", "A": "鉀補口服液的學名是 Potassium Gluconate" },
    {"Q": "在哪裡可以找到鉀補口服液的學名?", "A": "鉀補口服液的學名是 Potassium Gluconate" },
    {"Q": "口服液的商品名是如何得知的？", "A": "鉀補口服液的商品名是 K-Glu" },
    {"Q": "鉀補口服液的學名成份1是多少mg/mL?", "A": "312 mg/mL"},
    {"Q": "「怎樣衡量鉀補口服液的規格含量？」", "A": "「鉀補口服液的規格含量是 20mEq/15mL/amp」" },
    {"Q": "鉀補口服液的中文名是什麼？", "A": "鉀補口服液"}  ,
    {"Q": "鉀補口服液的藥理分類是什麼才會被歸類為?", "A": "Replenishers and Regulators of Water and Electrolytes"   },
    {"Q": "怎樣才能將鉀補口服液歸類為藥理分類?", "A": "Replenishers and Regulators of Water and Electrolytes"   },
    {"Q": "如何取得鉀補口服液的健保碼？", "A": "AC58956135"},
    {"Q": "健保碼 AC58956135 是如何生成的？", "A": "AC58956135"},
    {"Q": "誰可以提供鉀補口服液的健保碼 AC58956135？", "A": "AC58956135"},
    {"Q": "在哪裡可以找到鉀補口服液的健保碼 AC58956135？", "A": "AC58956135"},
    {"Q": "這個藥品的衛署字號是如何取得的？", "A": "衛部藥製字第058956號"},
    {"Q": "鉀補口服液的廠牌是什麼公司？", "A": "臺灣バイオテック（信東）" },
    {"Q": "「鉀補口服液的產地是在哪裡製造的？」", "A": "「臺灣」"},
    {"Q": "成人服用鉀補口服液需要多少毫升？", "A": "PO 15mL tid-qid" },
    {"Q": "鉀補口服液如何補充鉀離子？", "A": "鉀補口服液的作用是補充鉀離子"},
    {"Q": "鉀補口服液的副作用如何避免？", "A": "胃痙攣、嘔吐、噁心"},
    {"Q": "要如何減少鉀補口服液引起的胃痙攣？", "A": "胃痙攣、嘔吐、噁心"},
    {"Q": "如果出現嘔吐， and 噁心副作用，該如何處理？", "A": "胃痙攣、嘔吐、噁心"},
    {"Q": "鉀補口服液應該儲存在哪個溫度以下？", "A": "25℃以下" },
    {"Q": "鉀補口服液應如何服用？", "A": "口服" },
    {"Q": "「如何確定鉀補口服液的濃度？」", "A": "「新品 K-Glu 含 K 1.3 mEq/mL，舊品KCL solusion含 K 0.67 mEq/mL。」" },
    {"Q": "這種藥品怎麼服用？", "A": " Ibuprofen oral susp 液劑 20mg/mL, 60mL/btl" }  ,
    {"Q": "依普芬口服懸液劑的學名是怎麼確定的？", "A": "Ibuprofen" }  ,
    {"Q": "「依普芬口服懸液劑的商品名是什麼？」", "A": "「Ibuprofen」" },
    {"Q": "「依普芬口服懸液劑的成份是多少毫克每毫升？」", "A": "「20 mg/mL」"},
    {"Q": "「依普芬口服懸液劑的含量是多少毫克每毫升？」", "A": "「20mg/mL」" },
    {"Q": "依普芬口服懸液劑的中文名是什麼?", "A": "依普芬口服懸液劑" }  ,
    {"Q": "依普芬口服懸液劑的藥理分類是什麼型別?", "A": "非鴉片止痛劑和退燒劑" },
    {"Q": "依普芬口服懸液劑的健保碼是什麼?", "A": "AC43152151" }  ,
    {"Q": "衛署字號是多少呢？", "A": "衛署藥製字第043152號" },
    {"Q": "「依普芬口服懸液劑的廠牌是什麼公司？」", "A": "「Center（晟德）」" },
    {"Q": "依普芬口服懸液劑是在哪裡生產的？", "A": "臺灣" },
    {"Q": "依普芬口服懸液劑的作用是怎麼解熱消炎止痛的？", "A": "解熱消炎止痛" },
    {"Q": "依普芬口服懸液劑引起水腫的原因是什麼？", "A": "副作用"},
    {"Q": "怎樣預防胃痛這個副作用？", "A": "胃痛"},
    {"Q": "在使用依普芬口服懸液劑時， A如何避免暈眩？", "A": "暈眩"},
    {"Q": "腹痛這個副作用發生時應該怎麼做？", "A": "腹痛"},
    {"Q": "為什麼會出現腹瀉的副作用？", "A": "腹瀉"},
    {"Q": "如何識別過敏這個副作用？", "A": "過敏"},
    {"Q": "嘔吐這個副作用發生時需要怎樣照顧？", "A": "嘔吐"},
    {"Q": "噁心這個副作用可以透過什麼方法緩解？", "A": "噁心"},
    {"Q": "頭痛這個副作用的緩解方法是什麼？", "A": "頭痛"},
    {"Q": "依普芬口服懸液劑應該儲存在什麼溫度下？", "A": "室溫 (≦25℃)" },
    {"Q": "", "A": "" },
    {"Q": "如何使用依普芬口服懸液劑？", "A": "使用前須搖勻"},
    {"Q": "如果用藥後出現喉痛、口腔/黏膜潰瘍、皮疹等症狀，應該怎麼做？", "A": "宜立即就醫並考慮停藥"},
    {"Q": "百比停錠的藥品是多少毫克每顆?", "A": "2mg/tab" },
    {"Q": "百比停錠的學名是怎麼決定的？", "A": "Biperiden" },
    {"Q": "百比停錠的商品名是如何確定的?", "A": "Bipiden" }  ,
    {"Q": "百比停錠的學名成份是如何表示的？", "A": "百比停錠的學名成份是1是 Biperiden 2 mg"}  ,
    {"Q": "「百比停錠的規格含量是多少毫克每錠？」", "A": "「2mg/tab」" },
    {"Q": "«什麼是百比停錠的中文名？»", "A": "«百比停錠»" }  ,
    {"Q": "錠的藥理分類是什麼型別 ?", "A": " Centrally Active Anticholinergic Drugs"},
    {"Q": "百比停錠的健保碼是如何取得的?", "A": "AC369441G0" }  ,
    {"Q": "百比停錠的衛署字號是如何獲得的？", "A": "衛署藥製字第036944號"}  ,
    {"Q": "百比停錠的廠牌是哪一家藥廠？", "A": "瑞士藥廠" }  ,
    {"Q": "百比停錠的產地是在哪裡製造的?", "A": "臺灣" }  ,
    {"Q": "藥物引起的錐體外症狀的給藥頻率是多少次每天？", "A": "1-3 times/d"},
    {"Q": "百比停錠的作用是抗帕金森氏症，它是如何抗帕金森氏症的？", "A": "抗多巴胺受體，,,增加多巴胺的活性" },
    {"Q": "如何減少百比停錠的噁心副作用？", "A": "噁心"},
    {"Q": "百比停錠應該儲存在哪裡？", "A": "室溫" },
    {"Q": "百比停錠怎麼服用？", "A": "口服" },
    {"Q": "「為什麼百比停錠的用藥指導是避免操作機械或駕車？」", "A": "「避免操作機械或駕車是因為藥物可能會導致嗜睡、疲勞、協調不良等副作用。」" },
    {"Q": "使用Anticholinergic藥品時，<|begin_of_text|>2019要如何調整劑量？", "A": "慢慢增、減劑量以達最好療效。" },
    {"Q": "芙琳亞錠15毫克的藥品是如何口服的？", "A": "Leucovorin 口服 15mg/tab (Folina)" }  ,
    {"Q": "芙琳亞錠15毫克的學名是怎麼命名的?", "A": "Leucovorin" }  ,
    {"Q": "芙琳亞錠15毫克的商品名是怎麼取得的？", "A": "Folina" },
    {"Q": "芙琳亞錠15毫克的學名成份是如何被確定的？", "A": "Leucovorin 15 mg"},
    {"Q": "我們如何知道芙琳亞錠15毫克含有多少Leucovorin？", "A": "Leucovorin 15 mg"},
    {"Q": "為什麼芙琳亞錠15毫克的成份是Leucovorin？", "A": "Leucovorin 15 mg"},
    {"Q": "芙琳亞錠的規格含量是多少毫克每錠？", "A": "15mg/tab" },
    {"Q": "芙琳亞錠15毫克的中文名是什麼名稱？", "A": "芙琳亞錠15毫克" }  ,
    {"Q": "芙琳亞錠15毫克的藥理分類是etermined by what method?", "A": " Miscellaneous Specific Antidotes" },
    {"Q": "如何確定芙琳亞錠15毫克的藥理分類?", "A": "它是被歸類為Miscellaneous Specific Antidotes" },
    {"Q": "什麼藥品的健保碼是AC44248100？", "A": "芙琳亞錠15毫克" },
    {"Q": "這個藥品的衛署字號是如何取得的？", "A": "衛署藥製字第044248號" },
    {"Q": "芙琳亞錠15毫克的廠牌是什麼公司？", "A": "TTY Biopharm(東洋)" },
    {"Q": "芙琳亞錠15毫克的產地是哪個國家或地區？", "A": "臺灣"},
    {"Q": "巨幼紅細胞貧血癥應如何使用葉酸？", "A": "肌肉注射或口服，不超過每日1mg。"},
    {"Q": "葉酸拮抗劑所引起毒性如何改善？", "A": "芙琳亞錠15毫克的作用是改善" },
    {"Q": "芙琳亞錠15毫克的腹瀉副作用如何緩和？", "A": "腹瀉"},
    {"Q": "芙琳亞錠15毫克應該如何儲存？", "A": "室溫儲存" }  ,
    {"Q": "芙琳亞錠15毫克應該如何服用？", "A": "口服"},
    {"Q": "「什麼是Leucovorin的別名？」", "A": "「Folinic Acid, Folinate」" }  ,
    {"Q": " Const-K ER的藥效持續性是如何維持的？", "A": "康是鉀持續性藥效錠的藥品"},
    {"Q": "這種藥品如何提供穩定的鉀離子水平？", "A": "康是鉀持續性藥效錠的藥品"},
    {"Q": "為什麼Const-K ER能夠提供長時間的藥效？", "A": "康是鉀持續性藥效錠的藥品"},
    {"Q": "這種藥品如何控制鉀離子的釋放速率？", "A": "康是鉀持續性藥效錠的藥品"},
    {"Q": "Const-K ER的藥效持續性機理是什麼？", "A": "康是鉀持續性藥效錠的藥品"},
    {"Q": "藥效錠的學名「鉀持續性」是如何命名的？", "A": "康"},
    {"Q": "康是鉀持續性藥效錠的商品名是什麼?", "A": "Const-K ER" },
    {"Q": "康是鉀持續性藥效錠的學名成份1是什麼?", "A": "鉀持續性藥效錠的學名成份1是 Potassium Chloride 10 mEq" }  ,
    {"Q": "「康的鉀持續性藥效錠的規格含量是多少？」", "A": "「10mEq/750mg/tab」" },
    {"Q": "康是鉀持續性藥效錠的中文名是什麼命名的?", "A": "康是鉀持續性藥效錠" },
    {"Q": "康是鉀持續性藥效錠的藥理分類是什麼?", "A": "Replenishers and Regulators of Water and Electrolytes"},
    {"Q": "如何描述康是鉀持續性藥效錠的藥理分類?", "A": "Replenishers and Regulators of Water and Electrolytes"},
    {"Q": "康是鉀持續性藥效錠屬於哪一種藥理分類?", "A": "Replenishers and Regulators of Water and Electrolytes"},
    {"Q": "康是鉀持續性藥效錠的健保碼是多少？", "A": "AC60560100"},
    {"Q": "如何取得康是鉀持續性藥效錠的健保碼？", "A": "AC60560100"},
    {"Q": "在哪裡可以找到康是鉀持續性藥效錠的健保碼？", "A": "AC60560100"},
    {"Q": "如何識別康是鉀持續性藥效錠的健保碼？", "A": "AC60560100"} ,
    {"Q": "這個藥品的衛署字號是如何取得的？", "A": "康是鉀持續性藥效錠的衛署字號是衛部藥製字第060560號"}  ,
    {"Q": "康是鉀持續性藥效錠的廠牌是哪一家公司？", "A": "Impax Laboratories (Taiwan), Inc. for Bora Pharmaceutical(保瑞藥業委託益邦製藥)"},
    {"Q": "誰負責生產康是鉀持續性藥效錠？", "A": "Impax Laboratories (Taiwan), Inc. for Bora Pharmaceutical(保瑞藥業委託益邦製薬)"},
    {"Q": "康是鉀持續性藥效錠的授權製造商是誰？", "A": "Impax Laboratories (Taiwan), Inc. for Bora Pharmaceutical(保瑞藥業委託益邦製藥)"},
    {"Q": "康是鉀持續性藥效錠是在哪裡生產的?", "A": "臺灣" }  ,
    {"Q": "成人預防低鉀血癥需要服用多少mEq的康錠？", "A": "20 to 40 mEq/day"},
    {"Q": "成人預防低鉀血癥需要分多少次服用的康錠？", "A": "1 to 2 divided doses"},
    {"Q": "輕微到中度低鉀血癥需要服用多少mEq的康錠？", "A": "40 to 100 mEq daily in divided doses"},
    {"Q": "嚴重低鉀血癥需要每次服用多少mEq的康錠？", "A": "40 mEq po tid to qid"},
    {"Q": "兒童使用鉀持續性藥效錠的劑量是如何確定的？", "A": "兒童使用鉀持續性藥效錠的劑量尚未確定。"},
    {"Q": "康錠的鉀離子是如何補充的？", "A": "持續性藥效錠" },
    {"Q": "副作用的脹氣是如何出現的？", "A": "康是鉀持續性藥效錠"},
    {"Q": "使用康是鉀持續性藥效錠時腹痛是如何發生的？", "A": "康是鉀持續性藥效錠"},
    {"Q": "康是鉀持續性藥效錠可能引起腹瀉的機理是什麼？", "A": "康是鉀持續性藥效錠"},
    {"Q": "嘔吐副作用在使用康是鉀持續性藥效錠時是如何發生的？", "A": "康是鉀持續性藥效錠"},
    {"Q": "噁心副作用與康是鉀持續性藥效錠有什麼關聯？", "A": "康是鉀持續性藥效錠"},
    {"Q": "康是鉀持續性藥效錠應該如何儲存?", "A": "室溫(< 25°C)" },
    {"Q": "康錠的用法是如何服用的?", "A": "口服" },
    {"Q": "如果藥粒隨糞便完整排出 , 是正常的嗎？", "A": "是"},
    {"Q": "如何避免單次口服投與K+ > 40 mEq所造成的腸胃不適？", "A": "通常建議單次劑量不要超過25 mEq/dose"},
    {"Q": "為什麼單次口服投與K+ > 40 mEq會造成無法耐受的腸胃不適？", "A": "康是鉀持續性藥效錠的注意事項"},
    {"Q": "如何減輕腸胃道副作用？", "A": "一般建議單次劑量不要超過25 mEq/dose"},
    {"Q": "凡可復膠囊的藥品要如何服用?", "A": "口服 cap 125mg/cap (Vancover)" }  ,
    {"Q": "凡可復膠囊怎麼服用？", "A": "口服"},
    {"Q": "如何給病人服用凡可復膠囊？", "A": "口服"},
    {"Q": "在服用凡可復膠囊時需要注意什麼服用方法？", "A": "口服"},
    {"Q": "凡可復膠囊的商品名是怎麼取得的？", "A": "Vancover" }  ,
    {"Q": "凡可復膠囊中的活性成份125毫克是如何達到的？", "A": "Vancomycin 125 mg" },
    {"Q": "凡可復膠囊的規格含量是多少毫克每粒?", "A": "125mg/cap" },
    {"Q": "凡可復膠囊的中文名是什麼名字？", "A": "凡可復膠囊"}  ,
    {"Q": "「凡可復膠囊的藥理分類是什麼型別？」", "A": "「Glycopeptides」"},
    {"Q": "健保碼是多少呢?", "A": "AC60316100" }  ,
    {"Q": "凡可復膠囊的衛署字號是什麼時候核准的？", "A": "衛部藥製字第060316號"}  ,
    {"Q": "凡可復膠囊的廠牌是哪一家公司？", "A": " Orient PHARMA(友霖生技)" },
    {"Q": "凡可復膠囊是在哪裡生產的?", "A": "臺灣" }  ,
    {"Q": "成人非重症感染時，凡可復膠囊的劑量是多少毫克？", "A": "125 mg"},
    {"Q": "成人非重症感染時，凡可復膠囊需要每隔多長時間服用一次？", "A": "6 小時"},
    {"Q": "成人非重症感染時，凡可復膠囊需要連續服用多少天？", "A": "10 天"},
    {"Q": "成人重症感染時，凡可復膠囊的劑量是多少毫克？", "A": "500 mg"},
    {"Q": "成人重症感染時，凡可復膠囊需要每隔多長時間服用一次？", "A": "6 小時"},
    {"Q": "成人重症感染時，凡可復膠囊需要連續服用多少天？", "A": "10 天"},
    {"Q": "小孩復膠囊的劑量是多少？", "A": "40 mg/kg/day"},
    {"Q": "小孩復膠囊的給藥頻率是多久一次？", "A": "Q6-8H"},
    {"Q": "小孩復膠囊的治療天數是多久？", "A": "7-10 days"},
    {"Q": "小孩復膠囊的最大日劑量是多少？", "A": "2,000 mg/day"},
    {"Q": "凡可復膠囊的抗生素作用是如何發揮的？", "A": "抗生素" }  ,
    {"Q": "蕁麻疹這個副作用如何預防？", "A": "凡可復膠囊的副作用包含蕁麻疹"},
    {"Q": "儲存凡可復膠囊需要維持多少攝氏的室溫?", "A": "≦25℃" },
    {"Q": "凡可復膠囊應該如何服用？", "A": "口服" },
    {"Q": "凡可復膠囊敲碎後應該如何溶於飲用水？", "A": "直接敲碎膠囊後再溶於至少10 mL飲用水"},
    {"Q": "服用凡可復膠囊溶液需要在多久的時間內完成？", "A": "1小時內"},
    {"Q": "特魯希口服懸浮液的藥品是什麼？", "A": "Riluzole oral susp 5mg/mL, 300mL/btl (Teglutik)" }  ,
    {"Q": "特魯希口服懸浮液的學名是如何得知的？", "A": "Riluzole" }  ,
    {"Q": "特魯希口服懸浮液的商品名是什麼名字?", "A": "Teglutik"},
    {"Q": "如何知道特魯希口服懸浮液的商品名?", "A": "Teglutik"},
    {"Q": "在哪裡可以找到特魯希口服懸浮液的商品名?", "A": "Teglutik"},
    {"Q": "特魯希口服懸浮液的學名成份是如何表示的？", "A": "以mg/mL為單位，表示每毫升含5毫克Riluzole" },
    {"Q": "特魯希口服懸浮液的規格含量是多少毫克每毫升？", "A": "5mg/mL" }  ,
    {"Q": "特魯希口服懸浮液的中文名是什麼名字？", "A": "特魯希口服懸浮液"}  ,
    {"Q": "「特魯希口服懸浮液的藥理分類是如何被歸類的？」", "A": "「Neurologic Miscellaneous Agents」"},
    {"Q": "口服懸浮液的健保碼是什麼時候取得的？", "A": "BC28266166" }  ,
    {"Q": "特魯希口服懸浮液的衛署字號是什麼時候獲得的？", "A": "衛部藥輸字第028266號" },
    {"Q": "誰頒布了特魯希口服懸浮液的衛署字號？", "A": "衛部" },
    {"Q": "特魯希口服懸浮液的衛署字號是由哪個部門頒布的？", "A": "衛部" },
    {"Q": "特魯希口服懸浮液的廠牌是由哪家公司生產的?", "A": "Italfarmaco, S.A." },
    {"Q": "", "A": ""},
    {"Q": "成人ALS病人需要在餐前或餐後多久服用特魯希口服懸浮液？", "A": "1小時" }  ,
    {"Q": "在pediatrics中，小孩劑量怎麼確定？", "A": "安全性和療效未經證明。" }  ,
    {"Q": "特魯希口服懸浮液對肌萎縮脊髓側索硬化症的作用是如何發揮的？", "A": "特魯希口服懸浮液的作用是肌萎縮脊髓側索硬化症"},
    {"Q": "在治療肌萎縮脊髓側索硬化症時， and how does 特魯希口服懸浮液發揮其療效？", "A": "特魯希口服懸浮液的作用是肌萎縮脊髓側索硬化症"},
    {"Q": "為什麼特魯希口服懸浮液能夠對肌萎縮脊髓側索硬化症產生療效？", "A": "特魯希口服懸浮液的作用是肌萎縮脊髓側索硬化症"},
    {"Q": "頭痛的副作用如何緩和？", "A": "特魯希口服懸浮液的副作用包含頭痛"},
    {"Q": "特魯希口服懸浮液應該如何儲存？", "A": "室溫 (≦25℃)"},
    {"Q": "首次開啟特魯希口服懸浮液後，可以存放多久？", "A": "15天"},
    {"Q": "特魯希口服懸浮液應該如何給藥？", "A": "口服" },
    {"Q": "使用特魯希口服懸浮液前，藥瓶需要如何操作？", "A": "旋轉180度，手動輕搖至少30秒"},
    {"Q": "抽取適當劑量的方法是什麼？", "A": "以給藥注射器抽取對應的體積給藥"},
    {"Q": "給藥完成後需要做什麼？", "A": "清洗注射器"},
    {"Q": "特魯希口服懸浮液首次開啟後，如何儲存？", "A": "於室溫 (≦25℃)可存放15天。"},
    {"Q": "使用特魯希口服懸浮液前需要怎麼做？", "A": "將藥瓶旋轉180度，手動輕搖至少30秒，確保懸液均一性。"},
    {"Q": "如何抽取適當劑量的特魯希口服懸浮液？", "A": "以給藥注射器抽取對應的體積給藥。"},
    {"Q": "給藥完成後需要怎麼處理注射器？", "A": "須清洗注射器。"},
    {"Q": "硫酸嗎啡口服液的包裝單位是多少毫升每瓶？", "A": "60mL/btl"},
    {"Q": "", "A": ".sulphate口服液的學名是" },
    {"Q": "硫酸嗎啡口服液的商品名是什麼取得的？", "A": " Morphine Sulfate Oral Solution"}  ,
    {"Q": "硫酸嗎啡口服液的學名成份是如何量測的？", "A": "1毫米每毫升"},
    {"Q": "硫酸嗎啡口服液的有效成分濃度是多少？", "A": "2毫克每毫升"},
    {"Q": "硫酸嗎啡口服液中嗎啡的濃度是如何表達的？", "A": "2毫克每毫升"},
    {"Q": "硫酸嗎啡口服液的規格含量是多少？", "A": "2mg/mL 60mL/btl" }  ,
    {"Q": "硫酸嗎啡口服液的中文名是什麼？", "A": "硫酸嗎啡口服液"},
    {"Q": "", "A": "" }  ,
    {"Q": "硫酸嗎啡口服液的健保碼是什麼時候取得的？", "A": "AC49758151"},
    {"Q": "怎樣獲得硫酸嗎啡口服液的健保碼？", "A": "AC49758151"},
    {"Q": "誰可以提供硫酸嗎啡口服液的健保碼？", "A": "AC49758151"},
    {"Q": "在哪裡可以找到硫酸嗎啡口服液的健保碼？", "A": "AC49758151"},
    {"Q": "如何檢視硫酸嗎啡口服液的健保碼？", "A": "AC49758151"},
    {"Q": "硫酸嗎啡口服液的衛署字號是什麼時候取得的？", "A": "衛署藥製字第049758號" }  ,
    {"Q": "硫酸嗎啡口服液的廠牌是由誰生產的?", "A": "UBI Pharma Inc. for PPCD(管製藥品廠委託聯亞藥業)"   },
    {"Q": "哪家公司負責生產硫酸嗎啡口服液?", "A": "UBI Pharma Inc. for PPCD(管製藥品廠委託聯亞藥業)"   },
    {"Q": "硫酸嗎啡口服液的產地是哪裡?", "A": "臺灣" },
    {"Q": "成人需要多少毫克的硫酸嗎啡口服液?", "A": "5-30 mg q4h" },
    {"Q": "硫酸嗎啡口服液的小孩劑量是多少毫克每公斤？", "A": "0.2-0.5 mg/kg"},
    {"Q": "硫酸嗎啡口服液的小孩劑量的給藥間隔是多久？", "A": "q4-6h"},
    {"Q": "硫酸嗎啡口服液的小孩劑量是否需要根據情況而定？", "A": "as needed"},
    {"Q": "", "A": "" },
    {"Q": "硫酸嗎啡口服液導致心搏過速的機制是什麼？", "A": "-heart rate acceleration"},
    {"Q": "為什麼會出現皮疹副作用？", "A": "皮疹"},
    {"Q": "低血壓副作用是如何發生的？", "A": "低血壓"},
    {"Q": "硫酸嗎啡口服液導致尿滯留的原因是什麼？", "A": "尿滯留"},
    {"Q": "便秘副作用是如何發生的？", "A": "便秘"},
    {"Q": "硫酸嗎啡口服液導致腹瀉的機制是什麼？", "A": "腹瀉"},
    {"Q": "嘔吐副作用是如何發生的？", "A": "嘔吐"},
    {"Q": "硫酸嗎啡口服液導致噁心副作用的原因是什麼？", "A": "噁心"},
    {"Q": "硫酸嗎啡口服液應該如何儲存？", "A": "小於 30℃ 儲存" },
    {"Q": "硫酸嗎啡口服液應如何給藥？", "A": "口服"},
    {"Q": "冠欣持續性藥效膜衣錠是一種每錠含有多少毫克的口服藥品？", "A": "60mg/tab"},
    {"Q": "冠欣持續性藥效膜衣錠的學名是如何得知的？", "A": "Isosorbide Mononitrate" },
    {"Q": "「冠欣持續性藥效膜衣錠的商品名是什麼方式決定？」", "A": "「冠欣持續性藥效膜衣錠的商品名是Coxine」"},
    {"Q": "冠欣持續性藥效膜衣錠的學名成份是多少毫克？", "A": "60 mg" }  ,
    {"Q": "冠欣持續性藥效膜衣錠的規格含量是多少mg/tab?", "A": "60mg/tab"  },
    {"Q": "「冠欣持續性藥效膜衣錠的中文名是什麼？」", "A": "「冠欣持續性藥效膜衣錠」"},
    {"Q": "冠欣持續性藥效膜衣錠的藥理分類是由什麼機轉決定？", "A": "Nitrates" },
    {"Q": "冠欣持續性藥效膜衣錠的健保碼是如何取得的？", "A": "AC49018100" }  ,
    {"Q": "冠欣持續性藥效膜衣錠的衛署字號是多少?", "A": "衛署藥製字第049018號" },
    {"Q": "冠欣持續性藥效膜衣錠的廠牌是什麼公司生產的?", "A": "Synmosa(健喬信元)" },
    {"Q": "「冠欣持續性藥效膜衣錠的產地是哪裡生產的？」", "A": "「臺灣」"},
    {"Q": "冠欣持續性藥效膜衣錠對心臟衰竭、狹心症的作用是如何發揮的？", "A": "冠欣持續性藥效膜衣錠的作用是心臟衰竭，狹心症" },
    {"Q": "冠欣持續性藥效膜衣錠引起頭痛的原因是什麼？", "A": "冠欣持續性藥效膜衣錠的副作用包含頭痛"},
    {"Q": "冠欣持續性藥效膜衣錠應該儲存在哪種溫度以下？", "A": "小於 25°C" },
    {"Q": "冠欣持續性藥效膜衣錠應該如何服用？", "A": "口服" },
    {"Q": "冠欣持續性藥效膜衣錠怎麼剝半？", "A": "可剝半，但不宜磨粉或嚼碎"},
    {"Q": "為什麼不能把冠欣持續性藥效膜衣錠磨粉？", "A": "可剝半，但不宜磨粉或嚼碎"},
    {"Q": "冠欣持續性藥效膜衣錠是否可以嚼碎？", "A": "可剝半，但不宜磨粉或嚼碎"},
    {"Q": "『如何給喘悅長效錠_Administration？』", "A": "口服" }  ,
    {"Q": "「喘悅長效錠的學名是什麼？」,,<|begin_of_text|>1999，", "A": "「Aminophylline」"},
    {"Q": "喘悅長效錠的商品名是多少？", "A": "Antiasth"},
    {"Q": "『喘悅長效錠每片含有多少毫克的阿米諾菲林？』", "A": "『225 mg』"}  ,
    {"Q": "喘悅長效錠每片含有多少毫克的有效成分？", "A": "225mg/tab" },
    {"Q": "喘悅長效錠(6/片)的中文名是什麼?", "A": "喘悅長效錠(6/片)" }  ,
    {"Q": "喘悅長效錠的藥理分類是什麼?", "A": "Xanthine derivatives" }  ,
    {"Q": "喘悅長效錠的健保碼是多少？", "A": "AC32286100"},
    {"Q": "如何得知喘悅長效錠的健保碼？", "A": "AC32286100"},
    {"Q": "在哪裡可以找到喘悅長效錠的健保碼？", "A": "AC32286100"},
    {"Q": "這個藥品的衛署字號是如何取得的？", "A": "衛署藥製字第032286號" },
    {"Q": "「如何知道喘悅長效錠的廠牌？」", "A": "「回春堂」"},
    {"Q": "「喘悅長效錠的產地是哪裡？」", "A": "「臺灣」"},
    {"Q": "「喘悅長效錠需要以何種方式服用？」,<|begin_of_text|>201、", "A": "「口服」"}  ,
    {"Q": "成人使用喘悅長效錠需要每次服用多少毫克？", "A": "225-450 mg" },
    {"Q": "喘悅長效錠的小孩劑量是根據什麼計算的？", "A": "12-20mg/kg/day"},
    {"Q": "喘悅長效錠(6/片)的作用是什麼方式支氣管擴張?", "A": "支氣管擴張" },
    {"Q": "喘悅長效錠引起心搏過速的副作用是如何出現的？", "A": "心搏過速"},
    {"Q": "為什麼使用喘悅長效錠會導致失眠？", "A": "失眠"},
    {"Q": "喘悅長效錠引起發抖的副作用是如何出現的？", "A": "發抖"},
    {"Q": "使用喘悅長效錠後為什麼會感到煩躁不安？", "A": "煩躁不安"},
    {"Q": "喘悅長效錠引起嘔吐的副作用是如何出現的？", "A": "嘔吐"},
    {"Q": "使用喘悅長效錠後為什麼會感到噁心？", "A": "噁心"},
    {"Q": "喘悅長效錠引起頭痛的副作用是如何出現的？", "A": "頭痛"},
    {"Q": "", "A": "" },
    {"Q": "", "A": "" }  ,
    {"Q": "", "A": "" }  ,
    {"Q": "立普妥膜衣錠的藥品八碼是什麼方式取得的?", "A": "LIP4FD35" }  ,
    {"Q": "立普妥膜衣錠的每錠含有多少毫克的阿託伐他汀？", "A": "20" },
    {"Q": "立普妥膜衣錠的中文名是什麼?", "A": "立普妥膜衣錠" }  ,
    {"Q": "「立普妥膜衣錠的劑型是什麼形式？」", "A": "「膜衣錠」"},
    {"Q": "立普妥膜衣錠成人初次服用多少毫克？", "A": "10-20 mg"},
    {"Q": "立普妥膜衣錠成人維持劑量是多少毫克？", "A": "10-80 mg qd"},
    {"Q": "10-17歲青少年初次服用立普妥膜衣錠多少毫克？", "A": "10 mg qd"},
    {"Q": "10-17歲青少年最多可以增加到每天服用多少毫克的立普妥膜衣錠？", "A": "20 mg"},
    {"Q": "立普妥膜衣錠如何降低血管再造術與心絞痛的風險？", "A": "對於臨床上沒有冠心病的高血壓患者，但是至少有三個其他冠心病危險因子，包括第二型糖尿病、年紀大於等於55歲、微白蛋白尿或蛋白尿、吸煙、或第一等親在55歲(男性)或60歲(女性)前曾經發生冠心病事件"},
    {"Q": "立普妥膜衣錠對10-17歲兒童的最大日劑量是如何確定的？", "A": "20 mg/day"},
    {"Q": "立普妥膜衣錠的懷孕藥品分級是什麼?", "A": "X;" }, 
    {"Q": "立普妥膜衣錠如何降低膽固醇？", "A": "立普妥膜衣錠的作用包含可降低膽固醇"},
    {"Q": "立普妥膜衣錠如何降低三酸甘油酯？", "A": "立普妥膜衣錠的作用包含可降低三酸甘油酯"},
    {"Q": "立普妥膜衣錠如何降低低密度脂蛋白？", "A": "立普妥膜衣錠的作用包含可降低低密度脂蛋白"},
    {"Q": "立普妥膜衣錠如何降低極低密度脂蛋白？", "A": "立普妥膜衣錠的作用包含可降低極低密度脂蛋白"},
    {"Q": "立普妥膜衣錠如何減少中風及冠狀動脈疾病之發生率？", "A": "立普妥膜衣錠的作用包含減少中風及冠狀動脈疾病之發生率"},
    {"Q": "立普妥膜衣錠的頭痛副作用如何避免？", "A": "立普妥膜衣錠的副作用包含頭痛"},
    {"Q": "如何減少立普妥膜衣錠的腹痛副作用？", "A": "立普妥膜衣錠的副作用包含腹痛"},
    {"Q": "立普妥膜衣錠的便秘或腹瀉副作用如何控制？", "A": "立普妥膜衣錠的副作用包含便秘或腹瀉"},
    {"Q": "如何監控立普妥膜衣錠可能引起的肝功能異常？", "A": "立普妥膜衣錠的副作用包含肝功能異常"},
    {"Q": "如何減少立普妥膜衣錠的肌肉痛副作用？", "A": "立普妥膜衣錠的副作用包含肌肉痛"},
    {"Q": "如果出現立普妥膜衣錠的不良反應，該怎麼做？", "A": "若有不適，請洽醫師或藥師"},
    {"Q": "如何避免立普妥膜衣錠與環孢菌素同時使用？", "A": "Concomitant use of atorvastatin and cyclosporine should be avoided."},
    {"Q": "在患者接受 klarithromycin、itraconazole、ritonavir（加darunavir、fosamprenavir、lopinavir 或 saquinavir）治療時，如何調整立普妥膜衣錠的劑量？", "A": "In patients receiving clarithromycin, itraconazole, ritonavir (plus darunavir, fosamprenavir, lopinavir, or saquinavir), atorvastatin dose exceeding 20 mg/day requires clinical assessment to ensure the lowest effect dosage is employed."},
    {"Q": "如何預防立普妥膜衣錠引起的肌肉病變和腎功能不全？", "A": "Rhabdomyolysis with renal dysfunction secondary to myoglobinuria has been reported."},
    {"Q": "在開始statin治療前，如何進行肝功能測試？", "A": "Liver function test should be performed before starting statin therapy and as clinically indicated thereafter."},
    {"Q": "如何避免CYP3A4強效抑制劑對HMG-CoA reductase inhibitor的影響？", "A": "Potent CYP3A4 inhibitors such as cyclosporin, azole antifungals, macrolide antibiotics, HIV protease inhibitors, nefazodone and large quantities of grapefruit juice (> 1 quart/day) can raise the plasma level of HMG-CoA reductase inhibitors and may increase the risk of myopathy."},
    {"Q": "如何避免HMG-CoA reductase inhibitor和fibrate併用引起的肌肉病變風險？", "A": "Combination of HMG-CoA reductase inhibitors and fibrates may increase the risk of myopathy."},
    {"Q": "在哪些情況下，statin是禁用的？", "A": "Statins are contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases. Statins are contraindicated in pregnant or lactation women."},
    {"Q": "哪些因素可能增加statin引起的肌肉病變風險？", "A": "The risk of myopathy appears to be increased in patients receiving higher dose of statins; in patients with multisystem diseases, e.g. renal or hepatic impairment concurrent serious infections or hypothyroidism; small body frame and frailty; and in patients undergo surgery."},
    {"Q": "立普妥膜衣錠應該儲存在什麼溫度？", "A": "室溫20-25℃"}, 
    {"Q": "立普妥膜衣錠的藥商是哪一家公司？", "A": "暉致醫藥股份有限公司"},
    {"Q": "誰生產立普妥膜衣錠？", "A": "暉致醫藥股份有限公司"},
    {"Q": "立普妥膜衣錠是由哪家藥商製造的？", "A": "暉致醫藥股份有限公司"},
    {"Q": "立普妥膜衣錠的廠牌是哪一家公司？", "A": "PFIZER PHARMACEUTICALS LLC (Puerto Rico)(2013.10.16) PFIZER IRELAND PHARMACEUTICALS (Ireland)(old)"},
    {"Q": "What company is the manufacturer of Lipitor?", "A": "PFIZER PHARMACEUTICALS LLC (Puerto Rico)(2013.10.16) PFIZER IRELAND PHARMACEUTICALS (Ireland)(old)"},
    {"Q": "如何決定降血脂藥物的給付規定？", "A": "根據全民健康保險降血脂藥物給付規定表"},
    {"Q": "在急性冠狀動脈症候群病史中，如何進行藥物治療？", "A": "與藥物治療可並行，LDL-C≧70 mg/dL"},
    {"Q": "心血管疾病或糖尿病患者應如何進行藥物治療？", "A": "與藥物治療可並行，TC≧160 mg/dL或 LDL-C≧100 mg/dL"},
    {"Q": "在2個危險因子或以上中，如何進行藥物治療？", "A": "給藥前應有3-6個月非藥物治療，TC≧200 mg/dL或 LDL-C≧130 mg/dL"},
    {"Q": "在1個危險因子中，如何進行藥物治療？", "A": "給藥前應有3-6個月非藥物治療，TC≧240 mg/dL或 LDL-C≧160 mg/dL"},
    {"Q": "在0個危險因子中，如何進行藥物治療？", "A": "給藥前應有3-6個月非藥物治療，LDL-C≧190 mg/dL"},
    {"Q": "如何決定降三酸甘油酯藥物的給付規定？", "A": "根據全民健康保險降三酸甘油酯藥物給付規定表"},
    {"Q": "心血管疾病或糖尿病病人應如何進行藥物治療？", "A": "與藥物治療可並行，TG≧200 mg/dL且(TC/HDL-C > 5 或HDL-C < 40 mg/dL)"},
    {"Q": "無心血管疾病病人應如何進行藥物治療？", "A": "給藥前應有3-6個月非藥物治療，TG≧200 mg/dL且(TC/HDL-C > 5 或HDL-C < 40 mg/dL)"},
    {"Q": "立普妥膜衣錠的藥品異動從哪個批號開始採用新防偽標籤？", "A": "HH1255"},
    {"Q": "From which batch number did Lipitor tablets start using new anti-counterfeit labels?", "A": "HH1255"},
    {"Q": "婦力清錠的藥品怎麼服用？", "A": "Metronidazole tab 口服 250mg/Tab (Fuliclin)"},
    {"Q": "How is Fuliclin taken?", "A": "Orally, 250mg per tablet"}, 
    {"Q": "婦力清錠的學名是如何獲得的？", "A": "Metronidazole"}, 
    {"Q": "婦力清錠的商品名是怎麼定義的？", "A": " Fuliclin"}, 
    {"Q": "婦力清錠的學名成份是如何表示的？", "A": "Metronidazole 250 mg"},
    {"Q": "怎樣才能知道婦力清錠的學名成份？", "A": "Metronidazole 250 mg"},
    {"Q": "要如何寫出婦力清錠的學名成份？", "A": "Metronidazole 250 mg"},
    {"Q": "婦力清錠的含量是多少毫克每錠？", "A": "250mg/Tab"}, 
    {"Q": "婦力清錠的中文名是如何取得的？", "A": "婦力清錠"},
    {"Q": "婦力清錠的藥理分類是什麼型別的藥物？", "A": " Drugs Used in Anaerobic Infection"},
    {"Q": "婦力清錠的健保碼是多少？", "A": "AC01963100"},
    {"Q": "婦力清錠的衛署字號是多少?", "A": "衛署藥製字第001963號"},
    {"Q": "婦力清錠的廠牌是由哪一家製藥公司生產？", "A": "York pharmaceutical CO., LTD.(約克製藥)"},
    {"Q": "婦力清錠是在哪裡生產的？", "A": "臺灣"}, 
    {"Q": " Anaerobic infection成人劑量是多少mg/kg？", "A": "7.5 mg/kg"},
    {"Q": "對於非重症C. difficile diarrhea，Metronidazole的劑量是多少mg每多久？”", "A": "500 mg tid for 10-14 days"},
    {"Q": "治療細菌性陰道炎，Metronidazole的劑量是多少mg每多久？", "A": "500 mg bid for 7 days"},
    {"Q": " Acute amebic dysentery治療中，Metronidazole的劑量是多少mg每多久？”", "A": "750 mg tid for 5-10 days"},
    {"Q": " Amebic liver abscess治療中，Metronidazole的劑量是多少mg每多久？", "A": "500-750 mg tid for 5-10 days"},
    {"Q": " Trichomoniasis單次給藥的劑量是多少mg？", "A": "2g as a single dose"},
    {"Q": " Giardiasis治療中，Metronidazole的劑量是多少mg每多久？", "A": "250 mg tid for 5 days"},
    {"Q": "婦力清錠的小孩在吃什麼的情況下服用？", "A": "與食物一起服用"},
    {"Q": "婦力清錠用於厭氧性感染的小孩劑量是多少mg/kg，每幾小時一次，持續多久？", "A": "7.5 mg/kg q6h for 7-10 days or longer"},
    {"Q": "婦力清錠用於阿米巴症和巴蘭蒂達症的小孩劑量是多少mg/kg/day，分幾次服用，持續多久？", "A": "35-50 mg/kg/day in 3 divided doses for 10 days"},
    {"Q": "婦力清錠用於姜桿蟲病的小孩劑量是多少mg/kg，每幾小時一次，持續多久？", "A": "5 mg/kg tid for"},
    {"Q": "婦力清錠的抗生素作用是如何實現的？", "A": "婦力清錠的作用是抗生素"}, 
    {"Q": "婦力清錠的尿液變紅棕色的副作用是如何發生的？", "A": "婦力清錠的副作用包含尿液紅棕色"},
    {"Q": "金屬味這個副作用在服用婦力清錠時是如何出現的？", "A": "婦力清錠的副作用包含金屬味"},
    {"Q": "腹瀉這個副作用在服用婦力清錠時是如何引起的？", "A": "婦力清錠的副作用包含腹瀉"},
    {"Q": "噁心這個副作用在服用婦力清錠時是如何出現的？", "A": "婦力清錠的副作用包含噁心"},
    {"Q": "頭痛這個副作用在服用婦力清錠時是如何引起的？", "A": "婦力清錠的副作用包含頭痛"},
    {"Q": "婦力清錠應該儲存在什麼溫度下？", "A": "室溫 (≦30℃)"},
    {"Q": "婦力清錠要怎麼服用？", "A": "口服"}, 
    {"Q": "婦力清錠的用藥指導可能如何引起尿液變色？", "A": "尿液變色"},
    {"Q": "服用婦力清錠期間可能如何出現味覺改變？", "A": "出現金屬味覺"},
    {"Q": "在服用婦力清錠期間， of 何時候不能飲酒？", "A": "服藥期間"},
    {"Q": "除癲達口服懸浮液的藥品要如何儲存？", "A": "根據說明書，除癲達口服懸浮液（Oxcarbazepine oral susp 60mg/mL, 100mL/btl (Trileptal)）應該stored at room temperature not exceeding 25°C."},
    {"Q": "How should the medication of Oxcarbazepine oral suspension be stored?", "A": "According to the instruction manual, the Oxcarbazepine oral suspension (60mg/mL, 100mL/btl (Trileptal)) should be stored at room temperature not exceeding 25°C."},
    {"Q": "除癲達口服懸浮液的學名是如何取得的？", "A": "Oxcarbazepine"},
    {"Q": "How is the generic name of Tritace oral suspension obtained?", "A": "Oxcarbazepine"},
    {"Q": "除癲達口服懸浮液的商品名是如何確定的?", "A": "除癲達口服懸浮液的商品名是Trileptal"},
    {"Q": "除癲達口服懸浮液的學名成份是如何計算的？", "A": " Oxcarbazepine 60 mg/mL"},
    {"Q": "如何準備除癲達口服懸浮液的學名成份？", "A": " Oxcarbazepine 60 mg/mL"},
    {"Q": "除癲達口服懸浮液的學名成份是如何製備的？", "A": " Oxcarbazepine 60 mg/mL"},
    {"Q": "除癲達口服懸浮液的規格含量是多少mg/mL?", "A": "60mg/mL, 100mL/btl"},
    {"Q": "除癲達口服懸浮液的中文名是什麼叫法？", "A": "除癲達口服懸浮液"},
    {"Q": "What is the method to name 除癲達口服懸浮液 in Chinese?", "A": "It is called 除癲達口服懸浮液"},
    {"Q": "除癲達口服懸浮液的藥理分類是什麼方式決定的?", "A": "Anticonvulsants"}, 
    {"Q": "除癲達口服懸浮液的健保碼是多少？", "A": "BC23538123"},
    {"Q": "如何取得除癲達口服懸浮液的健保碼？", "A": "BC23538123"},
    {"Q": "除癲達口服懸浮液的健保碼在哪裡可以找到？", "A": "BC23538123"},
    {"Q": "誰可以提供除癲達口服懸浮液的健保碼？", "A": "BC23538123"},
    {"Q": "除癲達口服懸浮液的衛署字號是什麼時候核准的？", "A": "衛署藥輸字第023538號"},
    {"Q": "When was the license number of Rabeprazole Sodium for Oral Suspension approved?", "A": "衛署藥輸字第023538號"},
    {"Q": "除癲達口服懸浮液的廠牌是由誰生產的?", "A": "Delpharm Huningue S.A.S"},
    {"Q": "Who manufactures the factory brand of Rabeprazole oral suspension?", "A": "Delpharm Huningue S.A.S"},
    {"Q": "除癲達口服懸浮液的產地是哪一個國家?", "A": "法國"},
    {"Q": "成人使用除癲達口服懸浮液的劑量是如何開始的？", "A": "Initially, 600 mg/day in 2 divided doses."},
    {"Q": "除癲達口服懸浮液的小孩劑量是如何計算的？", "A": "Initially, 8-10 mg/kg/day in 2 divided dose. Max. 60 mg/kg/day."},
    {"Q": "How is the dosage of Rabeprazole oral suspension calculated for children?", "A": "Initially, 8-10 mg/kg/day in 2 divided dose. Max. 60 mg/kg/day."},
    {"Q": "除癲達口服懸浮液的作用是如何癲癇？", "A": "癲癇"},
    {"Q": "How does Rabeprazole oral suspension work to treat gastric ulcers?", "A": "Treats gastric ulcers"}, 
    {"Q": "副作用出現時，如何處理皮膚過敏？", "A": "除癲達口服懸浮液的副作用包含皮膚過敏"},
    {"Q": "當倦怠發生時，我們該如何應對！", "A": "除癲達口服懸浮液的副作用包含倦怠"},
    {"Q": "焦慮是副作用之一，如何減輕這種症狀？", "A": "除癲達口服懸浮液的副作用包含焦慮"},
    {"Q": "發抖是藥物的副作用，我們該如何處理！", "A": "除癲達口服懸浮液的副作用包含發抖"},
    {"Q": "嗜睡是副作用之一，如何避免這種情況？", "A": "除癲達口服懸浮液的副作用包含嗜睡"},
    {"Q": "暈眩是藥物的副作用，我們該如何應對！", "A": "除癲達口服懸浮液的副作用包含暈眩"},
    {"Q": "運動失調是藥物的副作用，如何減輕這種症狀？", "A": "除癲達口服懸浮液的副作用包含運動失調"},
    {"Q": "嘔吐是副作用之一，如何止吐！", "A": "除癲達口服懸浮液的副作用包含嘔吐"},
    {"Q": "複視是藥物的副作用，我們該如何處理！", "A": "除癲達口服懸浮液的副作用包含複視"},
    {"Q": "噁心是藥物的副作用，如何減輕這種症狀？", "A": "除癲達口服懸浮液的副作用包含噁心"},
    {"Q": "頭痛是藥物的副作用，我們該如何應對！", "A": "除癲達口服懸浮液的副作用包含頭痛"},
    {"Q": "除癲達口服懸浮液應該如何儲存？", "A": "小於 30°C 儲存；開封後可儲存7週。"},
    {"Q": "How should Rabeprazole oral suspension be stored?", "A": "Stored below 30°C; can be saved for 7 weeks after opening."},
    {"Q": "除癲達口服懸浮液應該怎麼服用？", "A": "口服"}, 
    {"Q": "oxcarbazepine與phenobarbital、phenytoin併用時，如何調整劑量？", "A": "可能須減少後者的劑量。"},
    {"Q": "oxcarbazepine誘導CYP3A4及CYP3A5的作用時，如何避免血中濃度降低？", "A": "將導致併用藥品之血中濃度降低(例如：carbamazepine、dihydropyridine類鈣離子拮抗劑及口服避孕藥)。"},
    {"Q": "莫比克錠 15 毫克的藥品是多少毫克每粒？", "A": "Meloxicam 口服 15mg/tab (Mopik)"},
    {"Q": "How many milligrams per tablet is Mopik 15 microgram tablets?", "A": "Meloxicam oral 15mg/tab (Mopik)"},
    {"Q": "莫比克錠15毫克的學名是什麼?", "A": "Meloxicam"},
    {"Q": "莫比克錠15毫克的商品名是什麼取得的？", "A": "Mopik"},
    {"Q": "How is the brand name of Mobic 15mg obtained?", "A": "Mopik"},
    {"Q": "莫比克錠 15 毫克的學名成份是什麼？", "A": "Meloxicam 15 mg"},
    {"Q": "莫比克錠的規格含量是多少毫克每錠？", "A": "15mg/tab"},
    {"Q": "「莫比克錠 15 毫克的中文名是什麼？」", "A": "「莫比克錠 15 毫克」"},
    {"Q": "What is the Chinese name of Mobic 15mg?", "A": "Mobic 15mg"},
    {"Q": "「莫比克錠15毫克的藥理分類是什麼型別的 medicated？」", "A": "「Antiinflammatory 和 anti-rheumatics: NSAIDs」"},
    {"Q": "What category of medication does Mobic 15mg belong to?", "A": "Antiinflammatory and anti-rheumatics: NSAIDs"},
    {"Q": "莫比克錠 15 毫克的健保碼是什麼方式取得的？", "A": "AC49146100"},
    {"Q": "莫比克錠 15 毫克的衛署字號是多少號?", "A": "衛署藥製字第049146號"},
    {"Q": "莫比克錠15毫克的廠牌是哪一家公司？", "A": "南光"},
    {"Q": "莫比克錠 15 毫克的產地是在哪裡生產的？", "A": "臺灣"}, 
    {"Q": "莫比克錠15毫克的消炎止痛作用是如何發生的？", "A": "消炎止痛"},
    {"Q": "要達到莫比克錠15毫克的消炎止痛效果，需要多久時間？", "A": "消炎止痛"},
    {"Q": "莫比克錠15毫克如何減少疼痛和炎症？", "A": "消炎止痛"},
    {"Q": "在體內，莫比克錠15毫克是如何實現消炎止痛的？", "A": "消炎止痛"},
    {"Q": "莫比克錠15毫克的藥理作用是如何產生消炎止痛效果的？", "A": "消炎止痛"},
    {"Q": "莫比克錠15毫克的水腫是如何發生的？", "A": "副作用"},
    {"Q": "莫比克錠15毫克導致胃痛是如何避免的？", "A": "副作用"},
    {"Q": "莫比克錠15毫克引起胃腸道潰瘍需要如何治療？", "A": "副作用"},
    {"Q": "莫比克錠15毫克導致暈眩是如何緩和的？", "A": "副作用"},
    {"Q": "莫比克錠15毫克引起腹瀉需要如何控制的？", "A": "副作用"},
    {"Q": "莫比克錠15毫克過敏反應是如何處理的？", "A": "副作用"},
    {"Q": "莫比克錠15毫克嘔吐情況是如何預防的？", "A": "副作用"},
    {"Q": "莫比克錠15毫克噁心感覺是如何緩和的？", "A": "副作用"},
    {"Q": "莫比克錠15毫克頭痛症狀是如何控制的？", "A": "副作用"},
    {"Q": "莫比克錠15毫克應該儲存在什麼溫度以下？", "A": "室溫（≦25℃）"},
    {"Q": "「莫比克錠15毫克應該如何給藥？」", "A": "「口服」"},
    {"Q": "", "A": ""}, 
    {"Q": "優力黴素口服懸液用顆粒的藥品是多少毫克每毫升?", "A": "25mg/mL"},
    {"Q": "優力黴素口服懸液用顆粒是一瓶多少毫升?", "A": "60mL/btl"},
    {"Q": "優力黴素口服懸液用顆粒的藥品名稱是什麼?", "A": "Ulexin"},
    {"Q": "如何表達優力黴素口服懸液用顆粒的濃度?", "A": "25mg/mL"},
    {"Q": "一瓶優力黴素口服懸液用顆粒有多少毫升的藥液?", "A": "60mL"},
    {"Q": "優力黴素口服懸液用顆粒的學名是什麼?", "A": "Cephalexin"},
    {"Q": "優力黴素口服懸液用顆粒的商品名是如何得知的?", "A": "優力黴素口服懸液用顆粒的商品名是 Ulexin"},
    {"Q": "How do you know the brand name of Ulexin oral suspension granules is?", "A": "The brand name of Ulexin oral suspension granules is Ulexin"},
    {"Q": "「優力黴素口服懸液用顆粒的學名成份要如何標示？」", "A": "「Cephalexin 25 mg/mL」"},
    {"Q": "「如何描述優力黴素口服懸液用顆粒的成分？」", "A": "「Cephalexin 25 mg/mL」"},
    {"Q": "「優力黴素口服懸液用顆粒的藥品名稱是如何表示的？」", "A": "「Cephalexin 25 mg/mL」"},
    {"Q": "優力黴素口服懸液用顆粒的規格含量是多少mg/mL？", "A": "25mg/mL, 60mL/btl"},
    {"Q": "「優力黴素口服懸液用顆粒的中文名是什麼？」", "A": "「優力黴素口服懸液用顆粒」"},
    {"Q": "What is the Chinese name of Optimox oral suspension granules?", "A": "Optimox oral suspension granules"},
    {"Q": "優力黴素口服懸液用顆粒的藥理分類是etermined by what?", "A": "第一代cephalosporins"},
    {"Q": "如何判斷優力黴素口服懸液用顆粒屬於哪一種藥理分類?", "A": "第一代cephalosporins"},
    {"Q": "優力黴素口服懸液用顆粒的健保碼是多少?", "A": "AC17280151"},
    {"Q": "優力黴素口服懸液用顆粒的衛署字號是多少號？", "A": "衛署藥製字第017280號"},
    {"Q": "優力黴素口服懸液用顆粒是由哪家公司生產的?", "A": "Swiss Pharm for U-Liang(優良委託瑞士藥廠)"}, 
    {"Q": "優力黴素口服懸液用顆粒的產地是在哪個國家？", "A": "臺灣"},
    {"Q": "哪裡生產優力黴素口服懸液用顆粒？", "A": "臺灣"},
    {"Q": "小孩使用優力黴素口服懸液用顆粒需要按照怎樣的劑量分配?", "A": "25-50 mg/kg/day 分為 4 次"},
    {"Q": "How should children take Augmentin oral suspension granules in terms of dosage distribution?", "A": "25-50 mg/kg/day divided into 4 times"},
    {"Q": "優力黴素口服懸液用顆粒的作用是抗生素，它是如何發揮抗生素作用的？", "A": "抗生素"}, 
    {"Q": "優力黴素口服懸液用顆粒的胃腸不適副作用如何避免？", "A": "胃腸不適"},
    {"Q": "優力黴素口服懸液用顆粒的暈眩副作用如何緩和？", "A": "暈眩"},
    {"Q": "優力黴素口服懸液用顆粒的過敏副作用如何預防？", "A": "過敏"},
    {"Q": "優力黴素口服懸液用顆粒的嘔吐副作用如何控制？", "A": "嘔吐"},
    {"Q": "優力黴素口服懸液用顆粒的噁心副作用如何減輕？", "A": "噁心"},
    {"Q": "優力黴素口服懸液用顆粒未泡製前應該如何儲存？", "A": "室溫儲存"},
    {"Q": "配製後的優力黴素口服懸液用顆粒可以在哪裡儲存？", "A": "冰箱中(冷藏)"},
    {"Q": "配製後的優力黴素口服懸液用顆粒可以儲存多久？", "A": "7天"},
    {"Q": "優力黴素口服懸液用顆粒應該如何給藥？", "A": "口服"},
    {"Q": "如何服用優力黴素口服懸液用顆粒？", "A": "請勿直接倒出乾粉服用。"},
    {"Q": "如何準備藥粉？", "A": "請先酌量加冷開水濕潤藥粉，接著持續加冷開水至60cc處。"},
    {"Q": "泡製後如何儲存藥劑？", "A": "需冰箱冷藏，使用前請搖勻。"},
    {"Q": "對penicillin過敏的患者應如何使用cephalosporin類藥品？", "A": "應特別小心。"},
    {"Q": "優力黴素口服懸液用顆粒不能怎麼服用？", "A": "直接倒出乾粉"},
    {"Q": "如何酌量加水以濕潤藥粉？", "A": "先酌量加冷開水"},
    {"Q": "完成泡製後需要做什麼？", "A": "遵照藥袋上用法說明服用"},
    {"Q": "泡製後應該如何儲存？", "A": "冰箱冷藏"},
    {"Q": "使用前需要做什麼？", "A": "搖勻"},
    {"Q": "對penicillin過敏的患者，應該怎麼使用cephalosporin類藥品？", "A": "特別小心"},
    {"Q": "", "A": ""},
    {"Q": "含磷口服液的學名是怎麼確定的？", "A": "Sodium Phosphate"},
    {"Q": "含磷口服液的商品名是如何決定 的？", "A": "含磷口服液的商品名是 Phosphate Oral Solution"},
    {"Q": "How is the brand name of phosphate oral solution determined?", "A": "The brand name of phosphate oral solution is Phosphate Oral Solution"},
    {"Q": "含磷口服液的學名成份是如何表示的？", "A": "Phosphate 0.97 mmol/mL"},
    {"Q": "How is the chemical composition of phosphate oral liquid expressed?", "A": "Phosphate 0.97 mmol/mL"},
    {"Q": "含磷口服液的規格含量是多少毫升每支？", "A": "20mL/amp"},
    {"Q": "What is the standard dosage of phosphorus oral solution per ampoule?", "A": "20mL/amp"}, 
    {"Q": "含磷口服液的中文名是如何確定？", "A": "含磷口服液"},
    {"Q": "含磷口服液的名稱是根據什麼命名？", "A": "含磷口服液"},
    {"Q": "如何翻譯含磷口服液的英文名稱為中文名稱？", "A": "含磷口服液"},
    {"Q": "含磷口服液的藥理分類是什麼?", "A": "Replenishers and Regulators of Water and Electrolytes"}, 
    {"Q": "含磷口服液的健保碼是多少？", "A": "X000224138"},
    {"Q": "如何取得含磷口服液的健保碼？", "A": "X000224138"},
    {"Q": "含磷口服液的健保碼在哪裡可以找到？", "A": "X000224138"},
    {"Q": "什麼是含磷口服液的健保碼？", "A": "X000224138"},
    {"Q": "如何知道含磷口服液的健保碼為何？", "A": "X000224138"},
    {"Q": "「含磷口服液的廠牌是怎麼取得的？」", "A": "「信東（Taiwan Biotech）」"},
    {"Q": "How is the brand of phosphorus oral solution obtained?", "A": " 信東（Taiwan Biotech）"},
    {"Q": "含磷口服液的產地是哪裡製造的?", "A": "臺灣"},
    {"Q": "Where is the manufacturing location of Phosphate Oral Solution?", "A": "Taiwan"},
    {"Q": "", "A": ""}, 
    {"Q": "含磷口服液的副作用如何避免？", "A": "胃腸脹氣、腹痛、腹瀉、嘔吐、噁心"},
    {"Q": "如何減少含磷口服液的胃腸脹氣副作用？", "A": "胃腸脹氣、腹痛、腹瀉、嘔吐、噁心"},
    {"Q": "降低含磷口服液腹痛副作用的方法是什麼？", "A": "胃腸脹氣、腹痛、腹瀉、嘔吐、噁心"},
    {"Q": "如何預防含磷口服液引起的腹瀉？", "A": "胃腸脹氣、腹痛、腹瀉、嘔吐、噁心"},
    {"Q": "含磷口服液 嘔吐副作用如何緩和？", "A": "胃腸脹氣、腹痛、腹瀉、嘔吐、噁心"},
    {"Q": "", "A": ""},
    {"Q": "", "A": ""},
    {"Q": "「諾快寧口服懸液用粉劑的學名是什麼藥品？」", "A": "「Amoxicillin/Clavulanic acid」"},
    {"Q": "What is the generic name of Augmentin oral suspension powder?", "A": "Amoxicillin/Clavulanic acid"},
    {"Q": "諾快寧口服懸液用粉劑的商品名是什麼?", "A": "Curam"},
    {"Q": "諾快寧口服懸液用粉劑的學名成份是多少mg/mL?", "A": "Amoxicillin 50 mg/mL"},
    {"Q": "諾快寧口服懸液用粉劑的Clavulanate濃度是多少mg/mL?", "A": "12.5"},
    {"Q": "What is the concentration of Clavulanate in suspension powder of Augmentin oral suspension?", "A": "12.5 mg/mL"},
    {"Q": "諾快寧口服懸液用粉劑的規格含量是多少？", "A": "50/12.5 mg/mL, 60mL/btl"},
    {"Q": "諾快寧口服懸液用粉劑的中文名是什麼?", "A": "諾快寧口服懸液用粉劑"},
    {"Q": "諾快寧口服懸液用粉劑的藥理分類是什麼決定因素？", "A": "Penicillins"},
    {"Q": "諾快寧口服懸液用粉劑的藥理分類如何被確定？", "A": "Penicillins"},
    {"Q": "根據什麼標準，ing 諾快寧口服懸液用粉劑的藥理分類為Penicillins？", "A": "Penicillins"},
    {"Q": "諾快寧口服懸液用粉劑的健保碼是如何取得的?", "A": "BC22931116"},
    {"Q": "How to obtain the health insurance code for Norovit oral suspension powder?", "A": "BC22931116"},
    {"Q": "諾快寧口服懸液用粉劑的衛署字號是什麼？", "A": "衛署藥輸字第022931號"},
    {"Q": "What is the health certificate number of Nuqing oral suspension powder?", "A": "Health Bureau Pharmaceutical Import No. 022931"}, 
    {"Q": "諾快寧口服懸液用粉劑是由哪家公司生產的？", "A": "Sandoz GmbH(山德士)"},
    {"Q": "哪家藥廠生產諾快寧口服懸液用粉劑？", "A": "Sandoz GmbH(山德士)"},
    {"Q": "諾快寧口服懸液用粉劑的製造商是誰？", "A": "Sandoz GmbH(山德士)"},
    {"Q": "諾快寧口服懸液用粉劑是製造在哪個國家？", "A": "奧地利"},
    {"Q": "Where is Nuo Ka Ning oral suspension powder manufactured?", "A": "Austria"},
    {"Q": "諾快寧口服懸液用粉劑的成人劑量是多少？", "A": "10 ml PO tid"},
    {"Q": "", "A": " Usual dose: Infants ≥3 months, Children, Adolescents <40 kg: amoxicillin 20 to 40 mg/kg/day divided into 3 doses; Max: amoxicillin 90 mg/kg/day"},
    {"Q": "諾快寧口服懸液用粉劑的抗生素作用是如何發揮的？", "A": "諾快寧口服懸液用粉劑的作用是抗生素"}, 
    {"Q": "諾快寧口服懸液用粉劑的丘疹副作用如何避免？", "A": "丘疹"},
    {"Q": "諾快寧口服懸液用粉劑的腹瀉副作用如何處理？", "A": "腹瀉"},
    {"Q": "諾快寧口服懸液用粉劑的過敏反應副作用如何預防？", "A": "過敏反應"},
    {"Q": "諾快寧口服懸液用粉劑的嘔吐副作用如何減輕？", "A": "嘔吐"},
    {"Q": "諾快寧口服懸液用粉劑的噁心副作用如何緩和？", "A": "噁心"},
    {"Q": "諾快寧口服懸液用粉劑的蕁麻疹副作用如何控制？", "A": "蕁麻疹"},
    {"Q": "諾快寧口服懸液用粉劑未開封時如何儲存？", "A": "於室溫(< 30°C)。"},
    {"Q": "諾快寧口服懸液用粉劑泡製後如何儲存？", "A": "需冷藏，可以存放7天。"},
    {"Q": "諾快寧口服懸液用粉劑應該如何給藥？", "A": "口服"},
    {"Q": "How should the Norvasc oral suspension powder be administered?", "A": "Orally"}, 
    {"Q": "諾快寧口服懸液用粉劑在使用前需要做什麼？", "A": "需泡製"},
    {"Q": "如何泡製諾快寧口服懸液用粉劑？", "A": "先加少量冷開水濕潤藥粉，接著持續加水至充填線(瓶身環狀凹陷處)"},
    {"Q": "在服藥前需要做什麼？", "A": "搖勻"},
    {"Q": "製備好的諾快寧口服懸液用粉劑需要存放在哪裡？", "A": "冷藏(攝氏2-8度)"},
    {"Q": "製備好的諾快寧口服懸液用粉劑需要在多少日內用完？", "A": "7日"},
    {"Q": "使用諾快寧口服懸液用粉劑時，需要注意什麼比例的差異？", "A": "Curam syrup之Amoxicillin/Clavulanate比例為4：1，和Augmentin syrup比例不同(7：1)，劑量上會有些許差異，請注意。"},
    {"Q": "普利腫錠的藥品是多少毫克每錠？", "A": "1mg/tab"},
    {"Q": "How many milligrams are in each tablet of Bumetanide?", "A": "1mg/tab"},
    {"Q": "普利腫錠的學名是如何得知的？", "A": "Bumetanide"},
    {"Q": "「普利腫錠的商品名是什麼得知的？」", "A": "「Budema」"},
    {"Q": "", "A": ""},
    {"Q": "", "A": ""},
    {"Q": "『普利腫錠的中文名是什麼？』", "A": "『普利腫錠』"},
    {"Q": "普利腫錠的藥理分類是什麼型別的？", "A": "Diuretics"},
    {"Q": "What category of pharmacological classification does Furosemide belong to?", "A": "Diuretics"},
    {"Q": "普利腫錠的健保碼是什麼取得的?", "A": "AC261541G0"},
    {"Q": "普利腫錠的衛署字號是多少號？", "A": "衛署藥製字第026154號"},
    {"Q": "普利腫錠的廠牌是由哪家公司生產？", "A": "成大藥品有限公司"},
    {"Q": "普利腫錠的產地是在哪裡製造的?", "A": "臺灣"},
    {"Q": "普利腫錠的作用是如何利尿的？", "A": "利尿"}, 
    {"Q": "普利腫錠的腹瀉副作用如何避免？", "A": "腹瀉"},
    {"Q": "如何減少普利腫錠的嘔吐副作用？", "A": "嘔吐"},
    {"Q": "噁心是普利腫錠的一種副作用，如何緩和這個症狀？", "A": "噁心"},
    {"Q": "普利腫錠的頻尿副作用可以如何控制？", "A": "頻尿"},
    {"Q": "普利腫錠應該如何存放？", "A": "室溫(≦25℃)；避光存放"},
    {"Q": "普利腫錠應該如何服用？", "A": "口服"},
    {"Q": "普利腫錠的用藥指導是可能造成哪些症狀需要避免操作機械或駕車？", "A": "頭暈"},
    {"Q": "", "A": ""},
    {"Q": "How to prepare Sevelamer Carbonate powder 800mg/pack (Renvela)?", "A": "Mix the contents of one packet with 60 mL of water"},
    {"Q": "「磷減樂口服懸液用粉劑的學名是什麼藥物？」", "A": "「Sevelamer Carbonate」"},
    {"Q": "「磷減樂口服懸液用粉劑的學名如何寫？」", "A": "「Sevelamer Carbonate」"}, 
    {"Q": "Renvela的商品名是什麼藥劑用粉劑？", "A": "磷減樂口服懸液"},
    {"Q": "哪種藥劑用粉劑的商品名是Renvela？", "A": "磷減樂口服懸液"},
    {"Q": "什麼藥劑用粉劑的商品名為Renvela？", "A": "磷減樂口服懸液"},
    {"Q": "?", "A": "Sevelamer Carbonate 800 mg"},
    {"Q": "磷減樂口服懸液用粉劑的規格含量是多少毫克每包?", "A": "800mg/pack"},
    {"Q": "磷減樂口服懸液用粉劑的中文名是什麼？", "A": "磷減樂口服懸液用粉劑"},
    {"Q": "What is the Chinese name of Phosphalugel oral suspension powder?", "A": "Phosphalugel oral suspension powder"}, 
    {"Q": "磷減樂口服懸液用粉劑被分類為還原劑和調節水和電解質的藥理機制是什麼?", "A": "Replenishers and Regulators of Water and Electrolytes"},
    {"Q": "磷減樂口服懸液用粉劑如何被歸類為藥理分類?", "A": "Replenishers and Regulators of Water and Electrolytes"},
    {"Q": "磷減樂口服懸液用粉劑的衛署字號是什麼?", "A": "衛署藥輸字第025733號"}, 
    {"Q": "磷減樂口服懸液用粉劑是由哪家公司生產的？", "A": "Genzyme Ireland Ltd(Genzyme)"},
    {"Q": "誰生產了磷減樂口服懸液用粉劑？", "A": "Genzyme Ireland Ltd(Genzyme)"},
    {"Q": "「磷減樂口服懸液用粉劑的產地是在哪個國家？」", "A": "「愛爾蘭」"},
    {"Q": "", "A": "0.8-2.4 g tid, po,"},
    {"Q": "藥劑磷減樂口服懸液用粉劑的作用是什麼?", "A": "高磷酸鹽血癥，磷結合劑"},
    {"Q": "如何治療高磷酸鹽血癥?", "A": "使用磷減樂口服懸液用粉劑"},
    {"Q": "磷減樂口服懸液用粉劑的作用是什麼型別的藥劑?", "A": "磷結合劑"},
    {"Q": "磷減樂口服懸液用粉劑的便秘副作用如何避免？", "A": "便秘"},
    {"Q": "磷減樂口服懸液用粉劑引起消化不良的處理方法是什麼？", "A": "消化不良"},
    {"Q": "磷減樂口服懸液用粉劑導致脹氣的緩解方法是什麼？", "A": "脹氣"},
    {"Q": "磷減樂口服懸液用粉劑引起腹痛的處理方法是什麼？", "A": "腹痛"},
    {"Q": "磷減樂口服懸液用粉劑導致腹瀉的緩解方法是什麼？", "A": "腹瀉"},
    {"Q": "磷減樂口服懸液用粉劑引起嘔吐的處理方法是什麼？", "A": "嘔吐"},
    {"Q": "磷減樂口服懸液用粉劑導致噁心的緩解方法是什麼？", "A": "噁心"},
    {"Q": "磷減樂口服懸液用粉劑應該如何儲存？", "A": "25℃以下"},
    {"Q": "", "A": ""},
    {"Q": "How do you take phospholipid oral suspension?", "A": "Take it orally"}, 
    {"Q": "藥粉要加在多少毫升的水中？", "A": "30 mL"},
    {"Q": "如何攪拌藥粉和水？", "A": "用力攪拌"},
    {"Q": "喝完藥劑需要多久時間？", "A": "30分鐘內"},
    {"Q": "藥粉要加在多少毫升的水中？", "A": "30 mL"},
    {"Q": "如何攪拌整包粉劑？", "A": "用力攪拌"},
    {"Q": "喝完藥液需要多少時間？", "A": "30分鐘內"},
    {"Q": "維骨力加強型口服溶液用粉劑應該如何準備？", "A": "按照產品標籤上的指示混合"},
    {"Q": "使用維骨力加強型口服溶液用粉劑需要多久時間？", "A": " MIX 1 sachet of powder with 150ml water"},
    {"Q": "如果我忘記喝維骨力加強型口服溶液用粉劑，該怎麼辦？", "A": "繼續正常 dosage, 不要 Double dose"},
    {"Q": "如何正確地儲存維骨力加強型口服溶液用粉劑？", "A": "Store in a cool dry place"},
    {"Q": "如果我需要長期使用維骨力加強型口服溶液用粉劑，該怎麼辦？", "A": "請遵循醫生的指示"},
    {"Q": "維骨力加強型口服溶液用粉劑的學名是什麼時候決定？", "A": " glucosamine sulfate"},
    {"Q": "When was the scientific name of osteostrong oral liquid powder determined?", "A": "glucosamine sulfate"},
    {"Q": "維骨力加強型口服溶液用粉劑的商品名是什麼叫？", "A": "Viartril-S powder for oral solution"},
    {"Q": "維骨力加強型口服溶液用粉劑的學名成份是如何表示的？", "A": " Glucosamine sulfate 1500 mg"},
    {"Q": "維骨力加強型口服溶液用粉劑的規格含量是多少mg/pack？", "A": "1500mg/pack"},
    {"Q": "維骨力加強型口服溶液用粉劑的中文名是什麼命名的?", "A": "維骨力加強型口服溶液用粉劑"},
    {"Q": "What is the Chinese name of 維骨力加強型口服溶液用粉劑 named after?", "A": "維骨力加強型口服溶液用粉劑"},
    {"Q": "維骨力加強型口服溶液用粉劑的藥理分類是什麼?", "A": "其他非類固醇抗-inflammatory 及抗風濕病藥"},
    {"Q": "維骨力加強型口服溶液用粉劑的衛署字號是什麼?", "A": "衛署藥輸字第023724號"}, 
    {"Q": "維骨力加強型口服溶液用粉劑是由哪家公司生產的？", "A": "RottaPharma"},
    {"Q": "維骨力加強型口服溶液用粉劑的製造商是誰？", "A": "RottaPharma"},
    {"Q": "維骨力加強型口服溶液用粉劑的產地是哪個國家？", "A": "愛爾蘭"}, 
    {"Q": "維骨力加強型口服溶液用粉劑的成人劑量是如何給藥的？", "A": "1 pack QD"},
    {"Q": "為了緩解退化性關節炎疼痛，維骨力加強型口服溶液用粉劑需要服用的頻率是多少？", "A": "1 pack QD"},
    {"Q": "成人使用維骨力加強型口服溶液用粉劑時，每天需要服用的劑量是多少？", "A": "1 pack QD"}, 
    {"Q": "維骨力加強型口服溶液用粉劑緩解退化性關節炎疼痛是如何發揮作用的?", "A": "緩解退化性關節炎疼痛"}, 
    {"Q": "維骨力加強型口服溶液用粉劑的便秘是如何避免的？", "A": "不明"},
    {"Q": "為什麼會出現胃痛副作用時該怎麼辦？", "A": "不明"},
    {"Q": "使用維骨力加強型口服溶液用粉劑時脹氣如何緩解？", "A": "不明"},
    {"Q": "維骨力加強型口服溶液用粉劑引起腹瀉要如何處理？", "A": "不明"},
    {"Q": "如果出現過敏反應副作用該怎麼急救？", "A": "不明"},
    {"Q": "嘔吐副作用發生時維骨力加強型口服溶液用粉劑的使用要如何調整？", "A": "不明"},
    {"Q": "噁心副作用發生時維骨力加強型口服溶液用粉劑的服用頻率要如何更改？", "A": "不明"}, 
    {"Q": "「維骨力加強型口服溶液用粉劑應該儲存在哪裡？」,<|begin_of_text|>201943，", "A": "「室溫 (≦25℃)」"},
    {"Q": "Where should the osteoporosis strengthening oral solution powder be stored?", "A": "At room temperature (≦25℃)"},
    {"Q": "維骨力加強型口服溶液用粉劑應該如何服用?", "A": "口服"},
    {"Q": "維骨力加強型口服溶液用粉劑應該怎麼沖調？", "A": "溶於一杯水(約100 mL)，與餐併服較佳。"},
    {"Q": "How should the calcium supplement oral solution powder be mixed?", "A": "Dissolve in a cup of water (about 100 mL) and take with meals for better results."}, 
    {"Q": "維骨力加強型口服溶液用粉劑應該怎麼溶解？", "A": "溶於一杯水（約100 mL）"},
    {"Q": "吃維骨力加強型口服溶液用粉劑時應該注意什麼？", "A": "與餐併服較佳"},
    {"Q": "泰復肯膠囊的藥品是多少mg/cap？", "A": "150mg/cap"},
    {"Q": "泰復肯膠囊每片含有多少mg的Fluconazole？", "A": "150mg/cap"},
    {"Q": "泰復肯膠囊的口服方法是什麼？", "A": "高口服"},
    {"Q": "泰復肯膠囊是一種什麼藥品？", "A": " Fluconazole cap (Diflucan)"},
    {"Q": "泰復肯膠囊每個膠囊含有多少mg的Fluconazole？", "A": "150mg/cap"}, 
    {"Q": "泰復肯膠囊的學名是多少？", "A": "Fluconazole"},
    {"Q": "What is the generic name of 泰復肯膠囊?", "A": "Fluconazole"},
    {"Q": "泰復肯膠囊的商品名是什麼藥品？", "A": "Diflucan"},
    {"Q": "泰復肯膠囊 (4/片) 的成份是多少毫克?", "A": "150 mg"},
    {"Q": "", "A": ""},
    {"Q": "How much does one capsule of 泰復肯膠囊 (4/片) contain?", "A": "150mg/cap"},
    {"Q": "泰復肯膠囊 (4/片) 的中文名是什麼時候確定的？", "A": "泰復肯膠囊 (4/片)"},
    {"Q": "When was the Chinese name of 泰復肯膠囊 (4/片) determined?", "A": "泰復肯膠囊 (4/片)"},
    {"Q": "泰復肯膠囊 (4/片) 的藥理分類是什麼型別？", "A": "Imidazoles 和 Triazoles"},
    {"Q": "泰復肯膠囊 (4/片) 的健保碼是什麼時候取得的？", "A": "BC21676100"},
    {"Q": "泰復肯膠囊的衛署字號是什麼?", "A": "衛署藥輸字第021676號"},
    {"Q": "What is the Ministry of Health and Welfare license number for 泰復肯膠囊?", "A": "Ministry of Health and Welfare Pharmaceutical License No. 021676"},
    {"Q": "泰復肯膠囊 (4/片) 的 廠 牌 是 哪 一 家公司？", "A": "Fareva Amboise(Fareva Amboise)"},
    {"Q": "What company manufactures 泰復肯膠囊 (4/片)?", "A": "Fareva Amboise(Fareva Amboise)"},
    {"Q": "泰復肯膠囊 (4/片) 的產地是哪個國家？", "A": "法國"}, 
    {"Q": "泰復肯膠囊的圖片範例是如何取得的？", "A": "ImageImageImage"},
    {"Q": "泰復肯膠囊的圖片範例是如何使用的？", "A": "ImageImageImage"},
    {"Q": "泰復肯膠囊的圖片範例是如何製作的？", "A": "ImageImageImage"},
    {"Q": "泰復肯膠囊的圖片範例是從哪裡獲得的？", "A": "ImageImageImage"}, 
    {"Q": "成人尿路感染症候群需要服用泰復肯膠囊多少毫克？", "A": "200~400 mg"},
    {"Q": "口腔念球菌感染初日需服用泰復肯膠囊多少毫克？", "A": "400 mg (or 6 mg/kg)"},
    {"Q": "食道念球菌感染後續每日需服用泰復肯膠囊多少毫克？", "A": "200~400 mg (3~6 mg/kg) qd"},
    {"Q": "口腔念球菌感染第二天後每日需服用泰復肯膠囊多少毫克？", "A": "100~200 mg"},
    {"Q": "念血癥初日需服用泰復肯膠囊多少毫克？", "A": "800 mg (or 12 mg/kg)"},
    {"Q": "cryptococcal腦膜炎誘導期需要每天服用泰復肯膠囊多少毫克？", "A": "800~1200 mg"},
    {"Q": "cryptococcal腦膜炎鞏固期需要每天服用泰復肯膠囊多少毫克？", "A": "800 mg"},
    {"Q": "cryptococcal腦膜炎維持期需要每天服用泰復肯膠囊多少毫克？", "A": "800 mg"},
    {"Q": "泰復肯膠囊的小孩劑量是多少毫克每公斤每次 ?", "A": "6~12 mg/kg/dose"},
    {"Q": "泰復肯膠囊的小孩劑量之間隔時間是多少 ?", "A": "qd (每日一次)"},
    {"Q": "泰復肯膠囊的小孩劑量的最大 dosage 是多少毫克 ?", "A": "Max 800 mg/dose"},
    {"Q": "泰復肯膠囊的抗黴菌作用是如何發揮的？", "A": "泰復肯膠囊 (4/片) 的作用是抗黴菌"}, 
    {"Q": "泰復肯膠囊的皮疹副作用是如何治療的？", "A": "皮疹"},
    {"Q": "泰復肯膠囊引起胃腸不適的處理方法是什麼？", "A": "胃腸不適"},
    {"Q": "泰復肯膠囊的黃疸副作用是如何消除的？", "A": "黃疸"},
    {"Q": "泰復肯膠囊引起搔癢的緩和方法是什麼？", "A": "搔癢"},
    {"Q": "泰復肯膠囊的腹脹副作用是如何解除的？", "A": "腹脹"},
    {"Q": "泰復肯膠囊引起腹瀉的處理方法是什麼？", "A": "腹瀉"},
    {"Q": "泰復肯膠囊的噁心副作用是如何減輕的？", "A": "噁心"},
    {"Q": "泰復肯膠囊 (4/片) 需要儲存在什麼溫度以下？", "A": "室溫 (< 30°C)"},
    {"Q": "", "A": ""},
    {"Q": "", "A": ""},
    {"Q": "錠的學名是什麼藥物得來的?", "A": "Piracetam"},
    {"Q": "「錠形藥品的商品名是怎樣被確定為 Syntam 的？」,<|begin_of_text|>200", "A": "「欣坦膜衣錠的商品名是 Syntam」"},
    {"Q": "錠的 Piracetam 1200 mg 成份是如何製備的？", "A": "欣坦膜衣錠的學名成份1是 Piracetam 1200 mg"},
    {"Q": "欣坦膜衣錠的規格含量是多少mg每錠？", "A": "1200mg/tab"},
    {"Q": "欣坦膜衣錠的中文名是什麼得來的？", "A": "欣坦膜衣錠"},
    {"Q": "", "A": ""},
    {"Q": "『怎麼才能找到欣坦膜衣錠的健保碼？』", "A": "答案是AC466811G0。"},
    {"Q": "錠的衛署字號是如何取得的？", "A": "衛署藥製字第046681號"},
    {"Q": "How did the tablet get its license number?", "A": "衛署藥製字第046681號"},
    {"Q": "「錠的廠牌是誰？」", "A": "「U-Liang For Synmosa（健喬信元委託優良）」"},
    {"Q": "Who is the manufacturer of the tablet?", "A": "U-Liang For Synmosa (健喬信元委託優良)"},
    {"Q": "欣坦膜衣錠的產地是哪裡生產的?", "A": "臺灣"}, 
    {"Q": "成人精神器官症候群需要服用欣坦膜衣錠的劑量是多少？", "A": "4.8 g/day，然後降低至 2.4 g/day。"},
    {"Q": "腦血管事故的急性階段需要服用欣坦膜衣錠的劑量是多少？", "A": "9-12 g/day。"},
    {"Q": "腦血管事故的亞急性和慢性階段需要服用欣坦膜衣錠的劑量是多少？", "A": "4.8-6 g/day。"},
    {"Q": "皮質起源肌陣 需要服用欣坦膜衣錠的劑量是多少？", "A": "7.2 g/day，每 3 或 4 天增加 4.8 g/day，最高可達 24 g/day。"},
    {"Q": " Dyslexia ", "A": " 8-13 "},
    {"Q": "「錠的作用是改善腦代謝功能的是如何實現的？」", "A": "「欣坦膜衣錠的作用是改善腦代謝功能」"}, 
    {"Q": "欣坦膜衣錠的皮膚炎副作用如何避免？", "A": "皮膚炎"},
    {"Q": "當患有暈眩時，應如何處理？", "A": "暈眩"},
    {"Q": "為什麼服用欣坦膜衣錠後會出現腹痛？", "A": "腹痛"},
    {"Q": "嘔吐副作用如何緩和？", "A": "嘔吐"},
    {"Q": "噁心副作用應該如何處理？", "A": "噁心"},
    {"Q": "頭痛副作用的緩和方法是什麼？", "A": "頭痛"},
    {"Q": "欣坦膜衣錠應該儲存在什麼溫度範圍內？", "A": "15-25℃"},
    {"Q": "What temperature range should Xintan film-coated tablets be stored in?", "A": "15-25°C"},
    {"Q": "錠的用法是怎樣口服？", "A": "欣坦膜衣錠的用法是口服"},
    {"Q": "佩裡波持續性藥效錠的藥品是如何生產的？", "A": "Paliperidone ER 口服 3mg/tab (Pardone)"},
    {"Q": "佩裡波持續性藥效錠的學名是如何確定的？", "A": " Paliperidone"},
    {"Q": "醫生如何決定使用佩裡波持續性藥效錠的適應症？", "A": " Paliperidone"},
    {"Q": "醫療人員如何評估佩裡波持續性藥效錠的藥效？", "A": " Paliperidone"},
    {"Q": "佩裡波持續性藥效錠需要遵循怎樣的給藥指引？", "A": " Paliperidone"},
    {"Q": "佩裡波持續性藥效錠的商品名是什麼?", "A": "Pardone"},
    {"Q": "佩裡波持續性藥效錠(7/片)的學名成份是多少毫克？", "A": "3 mg"},
    {"Q": "佩裡波持續性藥效錠每片含有的學名成份是什麼？", "A": "Paliperidone"},
    {"Q": "佩裡波持續性藥效錠的劑量是多少毫克每片？", "A": "3 mg"},
    {"Q": "佩裡波持續性藥效錠的規格含量是多少mg/片？", "A": "7/片是3mg/tab"},
    {"Q": "ペリボ持續性藥效錠（7/片）的中文名是什麼？", "A": "佩裡波持續性藥效錠（7/片）"},
    {"Q": "佩裡波持續性藥效錠的藥理分類是什麼種類？", "A": "非典型抗精神病藥"},
    {"Q": " Perebo 持續性藥效錠的健保碼是如何獲得的？", "A": " AC60259100"},
    {"Q": "How to obtain the health insurance code for Perebo sustained-release tablets?", "A": "AC60259100"},
    {"Q": "佩裡波持續性藥效錠的衛署字號是什麼?", "A": "衛部藥製字第060259號"},
    {"Q": "What is the Ministry of Health's license number for Periplus sustained-release tablets?", "A": "Ministry of Health Pharmaceutical License No. 060259"},
    {"Q": "佩裡波持續性藥效錠的廠牌是由哪一家公司生產的？", "A": "China Chemical & Pharmaceutical Co., Ltd. (CCPC)(中國化學製藥)"},
    {"Q": "Which company produces the Pelubipro sustained-release tablets?", "A": "China Chemical & Pharmaceutical Co., Ltd. (CCPC)(中國化學製薬)"},
    {"Q": "佩裡波持續性藥效錠的產地是哪裡?", "A": "臺灣"}, 
    {"Q": "成人佩裡波持續性藥效錠的劑量是多少?", "A": "3-12 mg once daily, administered in the morning."},
    {"Q": "當每天劑量超過6mg時，應如何增加劑量?", "A": "小增量3mg/day，間隔至少5天重新評估。"},
    {"Q": "佩裡波持續性藥效錠的最大劑量是多少?", "A": "12 mg/day"},
    {"Q": "什麼歲數的小孩可以服用佩裡波持續性藥效錠7/片，並且開始劑量是多少？", "A": "12-17 yr: 3 mg once daily"},
    {"Q": "如果需要增加佩裡波持續性藥效錠的劑量，如何進行劑量增幅？", "A": "may increase by 3 mg/day increments at intervals of more than 5 days."},
    {"Q": "", "A": "佩裡波持續性藥效錠(7/片)的作用是情緒穩定劑"}, 
    {"Q": "這些副作用如何影響病人的睡眠？", "A": "失眠"},
    {"Q": "肌張力改變是如何發生的？", "A": "肌張力改變"},
    {"Q": "姿態性低血壓如何防範？", "A": "姿態性低血壓"},
    {"Q": "唾液過多的症狀如何控制？", "A": "唾液過多"},
    {"Q": "錐體外路症狀（如手抖四肢僵硬等）如何緩解？", "A": "錐體外路症狀"},
    {"Q": "", "A": ""},
    {"Q": "佩裡波持續性藥效錠（7/片）的用法如何給藥？", "A": "口服"}, 
    {"Q": "如何使用佩裡波持續性藥效錠？", "A": "不可將藥錠嚼碎、剝半或磨粉"},
    {"Q": "如果藥錠排出體外，如何處理？", "A": "為正常現象"},
    {"Q": "服用佩裡波持續性藥效錠時，需要注意什麼？", "A": "可能影響思考、判斷力及運動能力，避免操作機械或駕車"},
    {"Q": "如何辨識藥錠排出的正常現象？", "A": "佩裡波持續性藥效錠的注意事項包含藥錠排出為正常現象。"},
    {"Q": "在老年失智病人身上如何降低致命機率？", "A": "佩裡波持續性藥效錠的注意事項包含在老年失智病人身上會增加致命機率。"},
    {"Q": "為避免操作危險機械，包括駕駛汽車，應如何監控思考、判斷力及運動能力？", "A": "佩裡波持續性藥效錠的注意事項包含可能影響思考、判斷力及運動能力，故應避免操作危險機械，包括駕駛汽車。"},
    {"Q": "喜博欣的藥品怎麼服用？", "A": "口服"},
    {"Q": "每粒喜博欣的藥品含有多少毫克的西普羅夫洛xac.in？", "A": "250mg/tab"},
    {"Q": "喜博欣的藥品是哪一種抗生素？", "A": "Ciprofloxacin"},
    {"Q": "喜博欣的學名是如何確定的？", "A": "它是根據藥品分類和命名規則確定的。"},
    {"Q": "How was the academic name of Ciprofloxacin determined?", "A": "It was determined based on drug classification and naming rules."},
    {"Q": "這個藥品的商品名是如何獲得的？", "A": "喜博欣"},
    {"Q": "How did this drug get its product name?", "A": "Ciprogen"},
    {"Q": "喜博欣的學名成份1是多少mg？", "A": "250 mg"},
    {"Q": "How many mg is the active ingredient of Ciproxin?", "A": "250 mg"},
    {"Q": "喜博欣藥丸每顆含有多少毫克的有效成分？", "A": "250mg/tab"},
    {"Q": "「喜博欣的藥理分類是什麼型別？」", "A": "「1580 Quinolones」"}, 
    {"Q": "這個健保碼是如何獲得的？", "A": "AB58253100"},
    {"Q": "怎麼取得這個健康保險碼？", "A": "AB58253100"},
    {"Q": "這個健保碼是經由什麼方式申請的？", "A": "AB58253100"},
    {"Q": "如何申報這個健康保險碼？", "A": "AB58253100"},
    {"Q": "這個健保碼是如何註冊的？", "A": "AB58253100"},
    {"Q": "這個藥品的衛署字號是如何取得的？", "A": "喜博欣的衛署字號是衛部藥製字第058253號"},
    {"Q": "瑞士藥廠的廠牌是如何被指定給喜博欣的？", "A": "瑞士藥廠是喜博欣的廠牌"}, 
    {"Q": "成人劑量的喜博欣是多少？", "A": "250-500 mg q12h"},
    {"Q": "嚴重感染時喜博欣的劑量是多少？", "A": "750 mg q12h"},
    {"Q": "十八歲以下的小孩劑量如何計算？", "A": "10 mg/kg/dose PO Q12H (max: 500 mg/dose)"},
    {"Q": "重症感染的小孩劑量如何計算？", "A": "15 to 20 mg/kg/dose PO Q12H (max: 750 mg/dose)"},
    {"Q": "小孩劑量的最大值是多少？", "A": "500 mg/dose (mild to moderate infections), 750 mg/dose (severe infections)"},
    {"Q": "喜博欣的抗生素作用是如何發揮的？", "A": "喜博欣的作用是抗生素"},
    {"Q": "喜博欣的抗生素效果是怎麼實現的？", "A": "喜博欣的作用是抗生素"},
    {"Q": "喜博欣是如何展現其抗生素功效的？", "A": "喜博欣的作用是抗生素"},
    {"Q": "喜博欣的失眠副作用如何避免？", "A": "失眠"},
    {"Q": "皮疹副作用在使用喜博欣時如何減輕？", "A": "皮疹"},
    {"Q": "使用喜博欣時如何預防光敏感？", "A": "光敏感"},
    {"Q": "暈眩副作用在服用喜博欣時如何緩和？", "A": "暈眩"},
    {"Q": "腹痛副作用在服用喜博欣時如何減輕？", "A": "腹痛"},
    {"Q": "使用喜博欣時如何預防腹瀉？", "A": "腹瀉"},
    {"Q": "噁心副作用在服用喜博欣時如何緩和？", "A": "噁心"},
    {"Q": "頭痛副作用在服用喜博欣時如何減輕？", "A": "頭痛"},
    {"Q": "儲存喜博欣需要在什麼溫度下？", "A": "室溫(25°C)"},
    {"Q": "儲存喜博欣時需要注意什麼？", "A": "避光儲存"},
    {"Q": "喜博欣的用法是如何給藥的？", "A": "口服"},
    {"Q": "用藥指導與制酸劑需要錯開多少小時？", "A": "至少兩小時"},
    {"Q": "是否可以與乳製品同時服用喜博欣？", "A": "不行"}, 
    {"Q": "如何避免喜博欣的口服劑型與含有Mg2+、AL3+之制酸劑或多價陽離子製劑併用的問題？", "A": "避免併用"},
    {"Q": "十八歲以下應該怎麼做以避免使用喜博欣？", "A": "不建議使用"},
    {"Q": "維諾心膜衣錠的藥品如何給藥?", "A": "口服"},
    {"Q": "每錠維諾心膜衣錠含有多少毫克Dipyridamole ?", "A": "75mg/tab"},
    {"Q": "維諾心膜衣錠是什麼品牌的藥品 ?", "A": "Parotin"},
    {"Q": "如何服用維諾心膜衣錠 ?", "A": "口服 75mg/tab"},
    {"Q": "維諾心膜衣錠所含有的有效成分是 ?", "A": "Dipyridamole"},
    {"Q": "「維諾心膜衣錠的學名是什麼才會被稱為 Dipyridamole？」", "A": "「維諾心膜衣錠的學名是 Dipyridamole」"},
    {"Q": "What makes Persantine's generic name called Dipyridamole?", "A": "Persantine's generic name is Dipyridamole"},
    {"Q": "「維諾心膜衣錠的商品名是什麼時候被確定的？」", "A": "「Parotin」"},
    {"Q": "『維諾心膜衣錠的學名成份是多少毫克？』", "A": "『75 mg』"},
    {"Q": "How many milligrams of active ingredient are in Persantin heart capsules?", "A": "75 mg"},
    {"Q": "維諾心膜衣錠的規格含量是多少mg/tab?", "A": "75"},
    {"Q": "「維諾心膜衣錠的中文名是什麼時候確定的？」", "A": "「維諾心膜衣錠」"},
    {"Q": "When was the Chinese name of Venlafaxine tablets determined?", "A": "Venlafaxine tablets"}, 
    {"Q": "維諾心膜衣錠的藥理分類是如何決定？", "A": "Antiplatelets Agents"},
    {"Q": "醫生們如何將維諾心膜衣錠歸類為抗血小板劑？", "A": "Antiplatelets Agents"},
    {"Q": "維諾心膜衣錠屬於哪一種藥理分類是根據什麼標準？", "A": "Antiplatelets Agents"},
    {"Q": "「維諾心膜衣錠的健保碼是如何獲得的？」", "A": "「AC285921G0」"},
    {"Q": "維諾心膜衣錠的衛署字號是如何取得的？", "A": "衛署藥製字第028592號"},
    {"Q": "How did Venlafaxine tablet get its license number?", "A": "It is licensed under No. 衛署藥製字第028592號"},
    {"Q": "", "A": ""},
    {"Q": "維諾心膜衣錠的產地是在哪裡生產的？", "A": "臺灣"},
    {"Q": "Where is Ventolin inhaler manufactured?", "A": "Taiwan"},
    {"Q": "成人維諾心膜衣錠的劑量是如何分配的？", "A": "150-225 mg 分為多次服用。"},
    {"Q": "抗血小板維諾心膜衣錠的劑量是如何分配的？", "A": "300-450 mg 分為多次服用。"},
    {"Q": "維諾心膜衣錠每日的最大劑量是多少？", "A": "800 mg。"},
    {"Q": "", "A": ""},
    {"Q": "How does Venofer work to prevent blood clots?", "A": "Its effect is to prevent blood clotting"}, 
    {"Q": "維諾心膜衣錠引起的心搏過速是如何發生的？", "A": "心搏過速"},
    {"Q": "低血壓是維諾心膜衣錠的副作用是如何出現的？", "A": "低血壓"},
    {"Q": "維諾心膜衣錠會導致暈眩是如何發生的？", "A": "暈眩"},
    {"Q": "腹瀉是維諾心膜衣錠的副作用是如何產生的？", "A": "腹瀉"},
    {"Q": "嘔吐是維諾心膜衣錠的副作用是如何出現的？", "A": "嘔吐"},
    {"Q": "潮紅是維諾心膜衣錠的副作用是如何發生的？", "A": "潮紅"},
    {"Q": "維諾心膜衣錠會導致噁心是如何發生的？", "A": "噁心"},
    {"Q": "頭痛是維諾心膜衣錠的副作用是如何出現的？", "A": "頭痛"},
    {"Q": "「維諾心膜衣錠應該如何服用？」", "A": "「口服」"},
    {"Q": "", "A": ""},
    {"Q": "威洛速膜衣錠的藥品是多少毫克每片？", "A": "400mg/tab"},
    {"Q": "How many milligrams per tablet are in Avelox?", "A": "400mg/tab"},
    {"Q": "威洛速膜衣錠的學名是什麼藥物?", "A": "Moxifloxacin"},
    {"Q": "「維洛速膜衣錠（5/片）的商品名是怎樣確定的？」", "A": "「維洛速膜衣錠（5/片）的商品名是 Avelox」"},
    {"Q": "威洛速膜衣錠 (5/片) 的學名成份是多少毫克?", "A": "400 mg"},
    {"Q": "威洛速膜衣錠的規格含量是多少毫克每片？", "A": "400mg/tab"},
    {"Q": "What is the standard dosage of �洛速膜衣錠 per tablet?", "A": "400mg/tab"},
    {"Q": "威洛速膜衣錠 (5/片)的中文名是什麼?", "A": "威洛速膜衣錠 (5/片)"},
    {"Q": "What is the Chinese name of � Luo Suo membrane-coated tablets (5/piece)?", "A": "威 Luo Suo membrane-coated tablets (5/piece)"},
    {"Q": "威洛速膜衣錠的藥理分類是什麼類別？", "A": "Quinolones"},
    {"Q": "威洛速膜衣錠的健保碼是如何取得的？", "A": "BC23223100"},
    {"Q": "How to obtain the health insurance code for Wei Luo Su film-coated tablets?", "A": "BC23223100"},
    {"Q": "威洛速膜衣錠的衛署字號是如何取得的？", "A": "衛署藥輸字第023223號"},
    {"Q": "威洛速膜衣錠 (5/片)的廠牌是哪一家公司？", "A": "Bayer Healthcare Manufacturing S.r.l.(拜耳)"},
    {"Q": "What company manufactures �洛速膜衣錠 (5/片)?", "A": "Bayer Healthcare Manufacturing S.r.l.(拜耳)"},
    {"Q": "威洛速膜衣錠 (5/片) 的產地是哪一個國家？", "A": "義大利"},
    {"Q": "「威洛速膜衣錠成人劑量是多少毫克時需要以何種方式給藥？」", "A": "「400 mg PO QD」"},
    {"Q": "How should the adult dose of 400mg Welipride tablets be administered?", "A": "400 mg PO QD"},
    {"Q": "威洛速膜衣錠在小孩使用時，<|begin_of_text|>200mg/片劑量的安全性和療效是如何確定的？", "A": "尚未確定"},
    {"Q": "威洛速膜衣錠的抗生素作用是如何發揮的？", "A": "抗生素"},
    {"Q": "How does Vilazodone film-coated tablets exert its antibiotic effect?", "A": "Antibiotic"}, 
    {"Q": "威洛速膜衣錠的失眠副作用是如何避免的？", "A": "未提供"},
    {"Q": "皮疹副作用在使用威洛速膜衣錠時如何處理？", "A": "未提供"},
    {"Q": "怎麼減少威洛速膜衣錠的光敏感副作用？", "A": "未提供"},
    {"Q": "威洛速膜衣錠導致陰道有分泌物及疼痛副作用如何治療？", "A": "未提供"},
    {"Q": "威洛速膜衣錠的虛弱副作用是如何預防的？", "A": "未提供"},
    {"Q": "怎麼減少威洛速膜衣錠的暈眩副作用？", "A": "未提供"},
    {"Q": "威洛速膜衣錠導致腹痛副作用如何處理？", "A": "未提供"},
    {"Q": "威洛速膜衣錠導致腹瀉副作用是如何預防的？", "A": "未提供"},
    {"Q": "怎麼減少威洛速膜衣錠的噁心副作用？", "A": "未提供"},
    {"Q": "威洛速膜衣錠導致頭痛副作用如何治療？", "A": "未提供"},
    {"Q": "「威洛速膜衣錠（5/片）的儲存條件如何？」", "A": "「小於 30°C 儲存」"},
    {"Q": "", "A": ""},
    {"Q": "How should �洛速膜衣錠 (5/片) be taken?", "A": "Orally"},
    {"Q": "威洛速膜衣錠與鐵劑、制酸劑至少要錯開多久時間服用?", "A": "兩小時"}, 
    {"Q": "何時應避免口服威洛速膜衣錠與制酸劑或多價陽離子製劑併用？", "A": "口服劑型與含有Mg2+、AL3+之制酸劑或多價陽離子製劑(Fe2+、Zn2+)併用時。"},
    {"Q": "在什麼情況下不建議使用威洛速膜衣錠？", "A": "十八歲以下。"},
    {"Q": "何種藥物不能與威洛速膜衣錠併用以避免延長QT間隔？", "A": "cisapride、erythromycin、antipsychotics、tricyclic antidepressants、procainamide、quinidine、amiodarone、sotalol。"}
]